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ABSTRACT

Lis1 haploinsufficiency in humans results in a “smooth brain” phenotype
called lissencephaly, and also causes severe cognitive and motor impairments
and epilepsy. Seizure severity and frequency typically worsens with time; patients
often die within the first decade due to seizure-induced aspiration and
pneumonia. Various mouse models have been used to examine the role of Lis1
during brain development, and it is clear that Lis1 regulates a microtubule motor,
cytoplasmic dynein. Intriguingly, Lis1 expression remains high in adult brains
indicating that it plays a role in mature systems. Indeed, our group found that Lis1
and several related proteins regulate dynein-dependent axon transport in
cultured adult rat sensory neurons. Here, we hypothesize that loss of Lis1 in adult
mice could lead to neurological disorders or other diseases.
In order to bypass the developmental impact of Lis1 loss, we first utilized a
tamoxifen inducible Cre-mediated recombination system driven by an actin
promoter to knock out Lis1 in adult mice (>8 weeks). We found that loss of Lis1 in
adult mice caused a progressive decline and ultimately death. These phenotypes
were not observed in any of a variety of control animals. Analysis of Cre activity
revealed it was not uniformly stimulated in all regions of the brain, and is highest
in the brainstem, where neuronal processes in regions known to control
cardiorespiratory networks were activated. In non-neuronal tissues, high level of
v

Cre activity was also detected in the hearts of tamoxifen induced Lis1 knockout
mice.
Secondly, to determine whether the lethal phenotype is caused by loss of
Lis1 in brainstems or in hearts, we generated a cardiomyocyte-specific inducible
lis1 knockout mouse model. Deletion of lis1 in hearts did not seem to induce
lethality or malaise in adult mice. This strengthened the hypothesis that the death
phenotype may be caused by Lis1 loss in neurons of the cardiorespiratory
brainstem network.
Lastly, examination of brain sections of experimental mice revealed
hallmarks of chromatolysis. Cultured DRG neurons from adult tamoxifen injected
experimental animals, but not controls, showed signs of axon pathology and
transport defects. Together, our results indicate that Lis1 is essential for adult
mammalian system, and its loss of function causes lethal phenotype in adult
mice, which may be resulted from dramatic altered neuronal function.
!
!!!

!
!
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GENERAL INTRODUCTION
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Lissencephlay is a severe brain developmental disorder, which is also
known as “smooth brain”. In patients with this disease, most of the cerebral
cortex lacks the grooves and gyrus as a normal brain does. Disorganization of
cerebral layers results in devastating consequences- defective cortex function
and early death, usually from worsened seizures.
Lis1 and brain development
Type I lissencephaly has been attributed to sporadic mutation in the
human LIS1 gene. LIS1 was identified as a subunit of a brain cytosolic isoform of
platelet-activating factor (PAF) acetylhydrolase. The first invertebrate LIS1related gene identified was nudF in the mold Aspergillus nidulans. Mutations in
nudF caused a severe defect in the migration of nuclei into and within the hyphal
processes, resulting in reduced colony size. This evidence suggested a
corresponding function for LIS1 in brain development. Nuclear migration occurs
within the processes of proliferating neuroepithelial cells and also some
differentiating neurons. Homozygous-null LIS1 mutant mice exhibited early postimplantation embryonic lethality, suggesting a basic cellular role for LIS1. Mice
with partial reduction of Lis1 displayed brain disorganization as well as cerebellar
defects. Neuronal migration abnormalities were observed in Lis1 mutants both in
vivo and in vitro(Hirotsune et al., 1998). These findings suggested LIS1 played a
cell-autonomous neuron-specific role for neuronal migration. The systematic
examination of the consequences of dosage reduction of LIS1 in mice revealed
defects in interkinetic nuclear migration and neuroblast proliferation(Gambello et
al., 2003).
2

In the hippocampus of Lis1+/- mice, synaptic transmission was severely
disrupted, demonstrating hyperexcitability at Schaffer collateral-CA1 synapses
and depression of mossy fiber-CA3 transmission(Fleck et al., 2000). A significant
alteration in function of inhibitory circuits was found within the malformed Lis1+/hippocampus. These hippocampal defects could provide a neuronal mechanism
for seizures associate with lissencephaly(Jones and Baraban, 2007). It is shown
that Lis1 haploinsufficiency can lead to abnormal cell proliferation, migration and
differentiation in the adult dentate gyrus(Wang and Baraban, 2007). Lis1
heterozygous mice also displayed abnormal motor behavior and spatial learning
and memory(Paylor et al., 1999).
Lis1/Dynein/Nudel Complex
It is demonstrated that Lis1 directly interacts with the cytoplasmic dynein
heavy chain (DHC) and Nudel, a murine homolog of the Aspergillus nidulans
nuclear migration mutant NudE(Niethammer et al., 2000). Lis1 and Nudel were
found to regulate the distribution of DHC along microtubules. The
Lis1/Nudel/DHC complex is seemed to be involved in retrograde axon transport
in the adult. This complex may play important roles of cell proliferation, cell
survival and/ or degeneration(Sasaki et al., 2000). It is speculated that disruption
in the Lis1/Nudel/DHC complex may result in functional impairment of axonal
transport, which could be responsible for neurological impairment in the
devastating disease.
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Roles of Lis1 in cellular functions
Our group found that Lis1 in enriched in neurons relative to levels in other
cell types. Lis1 interacts with the microtubule motor cytoplasmic dynein and may
stimulate specific dynein functions in neuronal migration and axon growth(Smith
et al., 2000). Dynein and Lis1 play an important role in microtubule advance
during growth cone remodeling associated with axonogenesis(Grabham et al.,
2007). Besides its role in brain development, Lis1 is also involved in other cellular
functions. Overexpression of Lis1 in cultured mammalian cells interferes with
mitotic progression and leads to spindle misorientation (Faulkner et al., 2000).
Lis1 has also been implicated in dynein-mediated nuclear migration in various
organisms(Xiang, 2003). Overexpression of dominant negative dynactin and Lis1
interfered with the rate of cell migration(Dujardin et al., 2003).
There has been controversy over how Lis1 mediates dynein-dependent
transport. One group showed that inhibition of Lis1 impaired anterograde
movement of cytoplasmic dynein(Yamada et al., 2008). Other group reported that
Lis1 inhibition had little effect on lysosomes but greatly inhibited axonal transport
of large, but not small vesicles(Yi et al., 2011). Our group previously reported that
Lis1 overexpression stimulated retrograde transport, while Lis1 RNAi significantly
reduced axon transport of lysosomes moving in axons of adult rat sensory
neurons(Pandey and Smith, 2011b). Also, depletion of Lis1 suppressed
mitochondrial motility in both anterograde and retrograde directions(Shao et al.,
2013).
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Axon transport and adult-onset neurodegenerative diseases (AONDs)
Axonal defects have been identified in mouse model of Alzheimer’s
disease. In this model, reduction of kinesin motor impaired axon transport
enhanced the frequency of axonal defects and increased amyloid-beta peptide
level (Stokin et al., 2005). Defective axonal transport of mitochondria was
observed in a mouse model of Alzheimer’s disease(Calkins et al., 2011). Axonal
transport deficits were found in an ALS mouse model(Bilsland et al., 2010).
Adult-onset neurodegenerative diseases are a group of neurological
disorder characterized by a progressive, age-dependent decline in neuronal
function and loss of selected neuronal populations. Many major AONDs including
Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
(ALS), display axonal pathologies including abnormal accumulations of proteins
and organelles(De Vos et al., 2008). Deficits in axon transport have been
documented in most AONDs, which commonly result in altered synaptic function
and axonal connectivity in these diseases(Morfini et al., 2009). A mouse model
postnatally deficient for proteins presenilin (PS) and expressing wild-type human
tau exhibited early tau pathology and axonal transport defects, which were
associated with reduced neurotrophin signaling, defective learning and memory
and impaired synaptic plasticity(Peethumnongsin et al., 2010). Mutations in !synuclein (!-Syn) cause Parkinsons’ disease (PD). Mutant mice expressing high
levels of A53T human !-Syns developed adult-onset neurodegenerative disease
with a progressive motor dysfunction leading to death(Lee et al., 2002). In A53T

5

mice, neurons in brainstem and spinal cord exhibited large axonal swelling,
somal chromatolytic changes, and nuclear condensation(Martin et al., 2006).

Lis1 knockout mouse models
Homozygous-null Lis1 mice are lethal at E7, while deletion of a single
allele of Lis1 exhibited hippocampal abnormalities, loosely paced granule cells
and neuronal migration abnormalities(Hirotsune et al., 1998). Multiple doses of
Lis1 had defects in interkinetic nuclear migration and neuroblast
proliferation(Gambello et al., 2003). Lis1+/- mice showed adult hippocampal
neurogenesis, abnormal cell proliferation, migration and differentiation in the
adult dentate gyrus(Wang and Baraban, 2007). Lis1fl/fl;Pax2-Cre mice that had
Lis1 deletion in midbrain-hindbrain E8 did not survive past 0. Lis1fl/fl;Wnt-Cre
mice had neuronal loss with embryos dead E13.5. Lis1fl/fl;hGFAP Cre mice that
had Lis1 deletion in neuronal precursor cells of the neocortex and hippocampus
at E12.5-13.5 survived to P5, but missing the hippocampus. They also had
defects in apical spindle orientation in the ventricular zone (Yingling et al., 2008).
Lis1fl/fl;K14-Cre mice showed epidermal barrier function in desmosomes, which
resulted in perinatal lethality(Sumigray et al., 2011). Adolescent (4weeks)
Lis1+/fl;CamKCre mice exhibited deficits in social interaction and dendritic
protrusion density(Sudarov et al., 2013).

6

Cardiorespiratory control network
In this study, we utilized a tamoxifen inducible Cre-mediated recombination
system to determine if loss of Lis1 in adult mice could result in any neurological
diseases. We found out Lis1 depletion in adult mice leads to progressive decline
and ultimate death. We speculate that this death phenotype could be due to
defects in cardiorespiratory network in brainstem, which controls heart rate and
breathing. Medulla oblongata is located in lower part of the brainstem, which
carries out life sustaining function such as breathing, swallowing and heart rate.
The pons sits directly above the medulla, connecting upper and lower parts of the
brain. A network of neurons located within the brainstem are involved in
regulating cardiorespiratory activity(Smith et al., 2007). The circuitry is located in
the dorsal respiratory group and ventral respiratory column(VRC) of the medulla
oblongata as well as in the dorsolateral pons(Bianchi et al., 1995) (Feldman et al.,
2003; Richter and Spyer, 2001). Cardiac vagal pre-ganglionic neurons of the
nucleus ambiguous receive inhibitory inputs during inspiration as well as
excitatory inputs during post-inspiration(Feldman and Del Negro, 2006). The
VRC is responsible for generating the respiratory rhythm. Retrotrpezoid nucleus
group and pre-Botzinger complex have been identified as principal components
of rhythm generation(Feldman and Del Negro, 2006; Feldman et al., 2003).
Neuronal circuits within the medullary pre-Botzinger complex generates the basic
rhythm of breathing, and then relay the respiratory pattern to cranial and spinal
motor neurons controlling respiratory muscles(Eisele and Jain, 1971; Hayashi
and McCrimmon, 1996). The vagus nerve is controlling the heart. Cardiac vagal
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pre-ganglionic motoneurons are located in dorsal vagal motonucleus and within
the nucleus ambiguous of the medulla oblongata(Jones, 2001; Spyer, 1994).
Inhibition of cardiac vagal motoneurons allows stimulus that enhances inspiration
increases heart rate, while inputs that suppress ventilation or prolong expiration
lower heart rate via cardiac vagal activation(Hyland et al., 2001).

8

CHAPTER 1
GENERATION OF AN INDUCIBLE LIS1 CONDTIONAL KNOCK OUT MOUSE MODEL

9

1.1INTRODUCTION
Our lab has previously demonstrated that perturbing Lis1 and its
regulators impacts dynein-dependent transport of lysosomes and mitochondria in
mature sensory neurons(Pandey and Smith, 2011a). Disruption in Lis1 regulatory
pathway could contribute to worsening lissencephaly symptoms, and may be
relevant to other neurological disorders.
It is difficult to determine how Lis1 pathways function in the mature
nervous system because Lis1 is so important in embryonic development. In order
to bypass the embryonic impact observed in conventional Lis1 knockouts, Lis1
should be removed from mature neurons. However, in cultured sensory neuronal
system, removing neurons to tissue culture can recapitulate developmental
programs rendering the neurons distinct from those in the intact animal. We
therefore generated a tamoxifen-inducible Cre mouse homozygous for a floxed
Lis1 allele. In this way Lis1 can be silenced at a chosen time after major
developmental processes have taken place. This not only allows us to determine
the importance of Lis1 in mature neuron, it provides a model for potential
therapeutic intervention to counteract symptoms of lissencephaly that may arise
post-developmentally as a result of transport defects.
Conditional Lis1 knockout was accomplished by inducing Cre-mediated
recombination post-developmentally to delete a floxed region of the Lis1 gene.
Lis1 is most abundantly expressed in nervous system while its expression is very
low in non-neuronal tissues, thus, we chose to use ! actin-driven promoter Cre to
10

ensure all neurons lose Lis1. Also, it would give the best chance of observing a
phenotype from an induced knockout and not restrict knock out to specific
subsets of neurons. The caveat is that this approach would also knock out Lis1 in
other adult tissues. However, as expression levels were much lower we expected
to observe a brain phenotype, if any.
There strains of commercially available mice will be crossed to generate
animals that are homozygous for a floxed Lis1 allele and hemizygous for an
inducible Cre recombinase allele and a Cre-reporter allele. The cureent mouse
model for lissencephlay, which carries a heterozygous deletion of Lis1 has
substantially milder phenotype than humans with Lis1 haploinsufficiency.
Although the Lis1 mutant mice appear to have slow or delayed neuronal
migration with an onset near E17.5, Lis1 het mutants have no apparent gross
phenotype compared to wild type mice except mild learning deficits in spatial and
motor learning (Paylor et al., 1999). Our transport studies indicate that Lis1
dosage can dramatically impact the number, speed, and run lengths of
organelles moving retrogradely in axons, and we suspect this contributes to
increased pathology in the longer human axons. Therefore, a homozygous
knockout of Lis1 serves the best model to study the impact of Lis1-dependent
transport defects in mice. On the other hand, the mild phenotype in the current
developmental model may be caused by compensatory mechanisms arising
because of the early loss of Lis1. If this is the case, knocking out a single allele in
mature neurons could result in a more severe adult phenotype. We are able to
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examine the impact of both heterozygous and homozygous conditional Lis1
knockouts and determine the effect neuronal survival, morphology and function.

1.2 MATHODS AND MATERIALS:
1.2.1 Animals: The three mouse strains used to generate inducible Lis1
knockout mice were purchased from Jackson lab(Figure 1.1).
a) Lis1+/fl (or 129S-Pafah1b1tm2Awb/J-JAX#008002): These mice possess
loxP sites flanking targeting vector containing PGKneo. This construct was
electroporated into 129S6/SvEvTac derived TC-1 embryonic stem (ES)
cells. Correctly targeted ES cells were injected into recipient blastocysts.
Mice that are homozygous for this allele are viable, fertile, normal in size
and do not display any gross physical or behavioral abnormalities. When
these mutant mice are bred to mice that express Cre recombinase,
resulting offspring will have exons 3 through 6 deleted in the cre
expressing tissue(s).
b) Cre-ERTM (or Tg(CAG-cre/Esr1*)5Amc/J-JAX #004453): These transgenic
mice have a tamoxifen-inducible cre-mediated recombination system
driven by the chicken beta actin promotor/enhancer coupled with the
cytomegalovirous (CMV) immediate-early enhancer. The transgene insert
contains a fusion product involving Cre recombinase and a mutant form of
the mouse estrogen receptor ligand-binding domain. The mutant mouse
estrogen receptor does not bind natural ligand at physiological
12

concentration but will bind the synthetic ligand, 4-hydroxytamoxifen.
Restricted to the cytoplasm, the Cre/ESR1 protein can only gain access to
the nuclear compartment after exposure to tamoxifen. When crossed with
a strain containing a loxP site flanked sequence of interest, the offspring
are useful for generating tamoxifen-induced, Cre-mediated targeted
deletions. Homozygous mice are not viable or fertile. Heterozygous mutant
mice are viable, fertile, normal in size and do not display any gross
physical or behavioral abnormalities.
c) R26GT (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J-Jax#007576): The
mT/mG (membrane-Tomato/membrane-Green) targeting vector was
designed with a CMV enhancer/chicken beta-actin promotor driving loxPflanked tdTomato protein sequence. An N-terminal membrane-tagged,
enhance green fluorescent protein sequence is distal to the second loxP
site. The entire mT/mG construct was inserted into the Gt(ROSA)26Sor
locus via electroporation of (129X1/SvJ x 129S1/Sv)F1-derived R1
embryonic stem(ES) cells. mT/mG homozygoutes can be identified by tail
or whole body epifluorescence. When bred to Cre recombinase
expressing mice, the offspring have the mT cassette deleted in the cre
expressing tissues, allowing expression of the membrane-targeted EGFP
(mG) cassette located just downstream. The CTB promotor allows
stronger and persistent expression of the fluorescent proteins compared to
the endogenous Gt(ROSA) locus alone. This double-fluorescent system
allows direct live visualization of both recombined and non-recombined
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cells at single cell resolution, offering an internal control for phenotypic
analysis of Cre-induced mosaic mutants.

1.2.2 Mouse breeding and colony maintenance
The University of South Carolina. The experimental protocols were
approved by the Animal Use Protocol (AUP) committee. All the transgenic mice
and knockout mice were maintained on its original genetic background. However,
when generating inducible Lis1 knockout mice by crossing three different mouse
strains, mixed genetic background could not be avoided. To minimize variation in
the genetic background, the males (Lis1fl/fl;actin-CreERTM; R26GT) and females
(Lis1fl/fl;R26GT) from the same generation were crossed to produce inducible Lis1
knockout mice, and mice from the same litter were compared. However, in order
to gather enough samples for statistical analysis, tissues from different animals
with the same genotype at different ages were pooled.
Mice were marked by ear puncture at weaning (3-4 weeks old), and
genomic DNA was extracted from tail for routine genotyping.
1.2.3 Genotyping:
Mice tails were digested in Tail buffer plus Protease K overnight at 55 oC.
2µl of tail digest was used as DNA templates for PCR reaction. Primers for Lis1
flox/flox: Sequence5'->3' TGA ATG CAT CAG AAC CAT GC; CCT CTA CCA
CTA AAG CTT GTT C. Primers for Cre : Sequence5'->3' CTA GGC CAC AGA
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ATT GAA AGA TCT; GTA GGT GGA AAT TCT AGC ATC ATC C. Primers for
R26GT : Sequence5'->3' CTC TGC TGC CTC CTG GCT TCT; CGA GGC GGA
TCA CAA GCA ATA ; TCA ATG GGC GGG GGT CGT.
A standard PCR reaction was set up as followed: For each tail DNA
sample, to make 25µl total volume, 6.5µl of H2O, 5.5 µl Master Mix 2.5µl each
primer and 2µl Tail DNA were added to PCR tubes. The reaction was performed
on a PCR thermocycler as follows: 94oC for 3 min for hotstart; 94 oC for 30s, 60
o

C for 1 min, 72 oC for 1min. Repeat steps above for 35 cycles. 10µl of the

reaction product was run on 5% polyacrylamide gel at 120V for 30 min. Gel was
stained with EB for 10min. DNA bands could be detected under UV light.

1.3 RESULTS:
1.3.1 Verifying Lis1+/fl , actin-Cre ERTM, R26GT mice by PCR
Lis1+/fl, Lis1 fl/fl mice were confirmed by PCR reactions. After gel
electrophoresis, we expected to see heterozygotes with a mutant band at 210 bp
and a wild type band at 167 bp; homozygous with one mutant band at 210 bp;
wild type with one band at 167bp(Figure 1.2B).
Heterozygous actin-Cre ERTM mice were identified by PCR using primers:
Sequence5'->3' CTA GGC CAC AGA ATT GAA AGA TCT; GTA GGT GGA AAT
TCT AGC ATC ATC C. A positive band at 100bp was identified as an actin-Cre
ERTM mouse. A negative band indicated a wild type allele for actin-Cre ERTM
gene(Figure 1.2C).
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R26GT mice were used a Cre reporter strain. It is reported that
heterozygous R26GT is sufficient to identify red fluorescence without Cre
recombination. Homozygous R26GT was detected with a single mutant band at
250 bp on 5% polyacrylamide gel(Figure 1.2D). Heterozygous R26GT was
identified with one mutant band at 250 bp and one wildtype band at 330bp. One
single band at 330 bp indicated wild type alleles for R26GT.

1.3.2 Summary of breeding strategy:
Heterozygous Lis1+/fl mice were intercrossed to produce Lis1 fl/fl
mice(Figure 1.3). One quarter of the offspring were homozygous for floxed Lis1.
Double floxed Lis1 mice were then crossed with Cre ERTM +/- mice to obtain
heterozygous lis1 flox; Cre ERTM. Heterozygous floxed Lis1; Cre ERTM mice were
backcrossed with homozygous Lis1 flox mice. One quarter of the offspring were
homozygous for Lis1 flox and heterozygous for Cre ERTM. Another quarter of the
offsprings were homozygous Lis1 flox without Cre ERTM, which served as a
control. Tissues from these mice were harvested to examine levels of proteins of
interest.
In order to generate inducible Lis1 knockout with Cre-reporter gene,
homozygous Lis1 flox mice were crossed with homozygous R26GT reporter
strain to obtain 1/4 offsprings carrying heterozygous Lis1 flox; R26GT. Lis1
flox+/-; R26GT+/- mice were then mated to produce homozygous Lis1
flox;R26GT strain. This strain were backcrossed with homozygous Lis1 flox;
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Heterozygous Cre ERTM to generate homozygous Lis1 flox;Heterozygous
Cre ERTM and R26GT stain. One half of the offspring were Homozygous Lis1 flox;
heterozygous R26GT without Cre ERTM, which were used as controls.
Additionally, to obtain a Cre ERTM; R26GT control, Cre ERTM strain was
bred with R26GT strain. Cre ERTM; R26GT controls are important as they carry a
Cre recombinase that we would know if activation of Cre upon tamoxifen injection
has any effect on mice phenotype.
In the analysis of Cre activation by reporter strain, homozygous and
heterozygous R26GT mice were not distinguished for each tissue. R26GT was
identified by tail epifluorescence.

1.3.3 Cre induction by tamoxifen :
We chose a tamoxifen inducible Cre system first described by Hayashi, S.
& McMahon, A.P (Hayashi and McMahon, 2002b). In the initial characterization
of these animals, Cre could be activated in various tissues including central
nervous system and in cultured cells. The recombination efficiency is dose
dependent. Multiple injections of as highest dose as 9mg of TM did not lead to
any obvious change in the behavior of the mice. Triple crosses produced mice
with homozygous floxed Lis1 alleles, one Cre-ER allele, and a Cre reporter
generated by L. & Luo (Muzumdar et al., 2007). This reporter gene codes for
both mTomato (red fluorophore) and GFP, but GFP is only produced if Cre
becomes active (i.e., enters the nucleus in response to tamoxifen). Two different
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control animals were also generated. The first control carries the floxed Lis1
alleles, but not the Cre-ER allele. The second control carries the Cre-ER allele,
but has wild type Lis1. A third control was a mock injection of the triple mutant
animal(Figure 1.4).
Adult mice (2-5 months old) were exposed to tamoxifen by intraperitoneal
(IP) injections. Different dosages of tamoxifen were used in the experiments with
low dose 2mg/day for 5 days, median dose 4mg/day for 5 days or high dose 8mg
/day for 2 days. It has been shown that increasing the dosage of tamoxifen
injected in the animals increased the frequency of Cre recombination 24h postinjection up to the maximum dose of 9mg of TM(Hayashi and McMahon, 2002a).
It revealed that high dose of TM resulted in a more rapid and more efficient
induction of recombination. The initial dosage of TM administered in adult mice
was determined based on the universal protocol published from Jackson Lab. It
states that 2mg of tamoxifen for 5 consecutive days is sufficient to drive Cre
activation in adult mice. It is reported that increasing the dosage of tamoxifen
injected and multiple rounds of injections would increase the efficiency of Cre
recombination. However, in the initial Cre induction studies, the variation in
weights of animals was not taken into account.
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1.4 DICUSSION:
The original three mouse strains purchased from Jackson Lab were from
different genetic backgrounds. When crossed them to generated inducible Lis1
knockout mouse model, the mixed background was obtained from different types
of matings. Different genetic backgrounds may influence the phenotypes of the
Lis1 inducible knockout mice. However, we selected the experimental and
control animals from the same litter to remove the side effects of different genetic
backgrounds. When a R26GT reporter strain was introduced, it allowed a direct
visualization of a fluorescent mouse. A single allele of R26GT is sufficient to
detect tail fluorescence(Muzumdar et al., 2007).
At least 8 weeks old mice were chosen as adult mice because this is when
mouse brain is fully developed and suited for study in adult system. Whether
older mice will respond to TM induction differently besides the weight than young
mice is unknown. It has been a concern that the blood-brain barrier would
prevent access of the drug. However, it has been shown that intraperitoneal
injection of TM (3mg/day for 5 days) resulted in efficient Cre recombination
including the brain(Hayashi and McMahon, 2002a). Examination of tissues
revealed the rapid onset of mG labeling within 24h following Cre
induction(Hayashi and McMahon, 2002a). However, there is a concern regarding
the lag between GFP expression and Lis1 knockdown. GFP expression may not
provide an accurate measure of Lis1 knockdown. Therefore, reduction of Lis1
protein expression level in specific tissues needs to be evaluated by western blot.
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This inducible knockout system can be used to remove activity of a gene
of interest at a certain stage of postnatal development. This approach would
allow us to overcome the developmental effects associated with germ-line
ablation. However, a certain gene may play several different roles in different
tissues at the same stage. Therefore, a tissue-specific Cre line may be
introduced to knock out the gene in a certain tissue. In this case, alternatively,
brain specific Cre mouse strain can be used to knock out Lis1 in central nerve
system.
In the course of generating double Lis1 knockout mouse model, a
heterozygous inducible Lis1 knockout was also generated. It will be valuable to
examine the differences between double Lis1 knockout and loss of single allele.
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Figure 1.1 The three mouse strains used to generate inducible Lis1
knockout mice. A.) Cre-ERTM: These transgenic mice have a tamoxifeninducible cre-mediated recombination system driven by the chicken ! actin
promotor/enhancer. The transgene insert contains a fusion product involving Cre
recombinase and a mutant form of the mouse estrogen receptor ligand-binding
domain. B.) R26GT reporter: These mice possess loxP sites on either side of a
membrane-targeted tdTomato(mT) cassette and express strong red fluorescence
in all tissues. mT/mG homozygotes can be identified by tail or whole body
epifluorescence. When bred to Cre recombinase expressing mice, the offspring
have the mT cassette deleted in the cre expressing tissues, C.)Lis1+/fl These
mice possess loxP sites flanking targeting vector containing PGKneo. When
these mutant mice are bred to mice that express Cre recombinase, resulting
offspring will have exons 2 through 6 deleted in the cre expressing tissue(s).
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A.

Figure 1.2 Mouse breeding and colony maintenance.
A.) Heterozygous Lis1+/fl mice(LlCCTT) were mated to produce Lis1 fl/fl mice.
One quarter of the offspring were homozygous for floxed Lis1. Homozygous
R26GT reporter(LLCCtt) mice were intercrossed to maintain the line. 100% of the
offspring would be homozygous R26GT mice. Heterozygous Cre mice (LLCcTT)
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B.

Figure 1.2 Mouse breeding and colony maintenance.
B.) Lis1+/fl, Lis1 fl/fl mice were confirmed by PCR reactions. After gel
electrophoresis, we expected to see heterozygotes with a mutant band at 210 bp
and a wild type band at 167 bp; homozygous with one mutant band at 210 bp;
wild type with one band at 167bp. Heterozygous actin-Cre ERTM mice were
identified by PCR. A positive band at 100bp was identified as an actin-Cre ERTM
mouse. A negative band indicated a wild type allele for actin-Cre ERTM gene.
\Homozygous R26GT was detected with a single mutant band at 250 bp on 5%
polyacrylamide gel. Heterozygous R26GT was identified with one mutant band at
250 bp and one wild-type band at 330bp. One single band at 330 bp indicated
wild type alleles for R26GT.
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Figure 1.3 Summary of breeding strategy. Heterozygous Lis1+/fl mice(LlCCTT)
were mated to produce Lis1 fl/fl mice (llCCTT). One quarter of the offspring were
homozygous for floxed Lis1. Double floxed Lis1 mice were then crossed with Cre
ERTM +/- mice to obtain heterozygous lis1 flox; Cre ERTM. Heterozygous floxed
Lis1; Cre ERTM mice(LLCcTT) were backcrossed with homozygous Lis1 flox mice.
One quarter of the offspring were homozygous for Lis1 flox and heterozygous for
Cre ERTM(llCcTT). Another quarter of the offsprings was homozygous Lis1 flox
without Cre ERTM, which served as a control. In order to generate inducible Lis1
knockout with Cre-reporter gene, homozygous Lis1 flox mice were crossed with
homozygous R26GT reporter strain(LLCCtt) to obtain 1/4 offsprings carrying
heterozygous Lis1 flox; R26GT(LlCCTt). Lis1 flox+/-; R26GT+/- mice were then
mated to produce homozygous Lis1 flox; R26GT strain(llCCtt). This strain was
backcrossed with homozygous Lis1 flox; Heterozygous Cre ERTM to generate
homozygous Lis1 flox; Cre ERTM and R26GT strain(llCcTt). One half of the
offspring were Homozygous Lis1 flox; heterozygous R26GT without Cre
ERTM(llCCTt), which were used as controls. To obtain a Cre ERTM; R26GT
control, Cre ERTM strain was bred with R26GT strain(LLCcTt).
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Figure 1.4 Experimental animals and Cre induction. Triple crosses produced
mice with homozygous floxed Lis1 alleles, one Cre-ER allele, and a Cre reporter
(lis1fl/fl;actCreERTM;R26GT). Cre is activated by TM injection. Three different
control animals were also generated. The first control carries the floxed Lis1
alleles, but not the Cre-ER allele (lis1fl/fl; R26GT). The second control carries the
Cre-ER allele, but has wild type Lis1(actCreERTM;R26GT). A third control was a
vehicle injection of the triple mutant animal (lis1fl/fl;actCreERTM;R26GT+corn oil).
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CHAPTER 2

THE EFFECT OF A TAMOXIFEN-INDUCIBLE ACTIN-CRE LIS1 KNOCKOUT IN
NERVE SYSTEM
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2.1INTRODUCTION
Lis1, the disease-causing gene for a “smooth brain” phenotype in which
regions of the cortex of lissencephaly patients are smooth in appearance
because of reduced or absent sulci and gyri. Children with lissencephaly have
severe mental retardation and other severe neurological abnormalities. They
often have feeding problems and hypotonia. A large majority of patients have
seizures during the first year. Patients often die due to status epilepticus or
pneumonia(Dobyns et al., 1993).
Neurons extend long processes, requiring efficient transport mechanisms
to allow communication of survival signals from the distal axon to the cell body
(Levy et al., 1985; Perlson et al., 2010). Anterograde axon transport plays a role
in supplying proteins and energy to the distal end, whereas retrograde transport
is involved in the clearance of misfolded and aggregated proteins form the axon
to the soma (2013).Retrograde axon transport is carried out by the multi-subunit
motor protein complex cytoplasmic dynein(Schnapp and Reese, 1989).
Defects in dynein-dependent axon transport have been linked to
psychiatric disorders and adult-onset neurodegenerative diseases. These
diseases are often characterized by cell body inclusions, axonal swellings, and
axon terminal degeneration(De Vos et al., 2008; Zuccato et al., 2010).
Huntington’s disease, a disorder of the basal ganglia, is caused by polyglutamate
repeat expansions in the Huntingtin protein(Zuccato et al., 2010). Huntingtin
interacts with dynein and the plus-end directed motor, kinesin(McGuire et al.,
2006). The Huntingtin-associated protein 1(HAP1) binds to mutant Huntingtin,
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and to dynactin, a dynein regulatory complex(Engelender et al., 1997; Li et al.,
1998). Phosphorylation of Huntingtin by the Akt/PKB kinase pathway in response
to IGF-1/PI3K signaling may cause a switch from dynein to kinesin binding to
influence the direction of vesicle transport(Caviston and Holzbaur, 2009;
Hafezparast et al., 2003; McGuire et al., 2006). Recently basal ganglia defects
were reported in a mouse with a point mutation in dynein heavy chain (the
catalytic subunit)(Braunstein et al., 2010). Finally, mutations in dynactin that
cause cytoplasmic inclusions have been found in eight families with Perry
Syndrome, a disorder characterized by early-onset Parkinsonism, depression
weight loss and hypovertilation(Strom et al., 2008). Amyotrophic Lateral Sclerosis
(ALS) and similar motor neuron disease are also linked to transport. ALS-like
symptoms have been observed in mice with dynein point mutations, and dynein
binds to a mutant form of superoxide dismutase (SOD1) found in familial ALS,
resulting in the formation of large inclusions containing mutant SOD1(Laird et al.,
2008). A mutation in a subunit of dynactin was found in a family with a lower
motor neuron disease, and expression of the mutant protein caused motor
neuron disease in transgenic mice(Puls et al., 2003).
Impairment of axonal transport has also been related to other
neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease,
and several motor neuron diseases. Several studies reported that transgenic
mice overexpressing wild-type or mutant amyloid precursor protein (APP)(Salehi
et al., 2006), mutant presenilin1 (PS1) (Lazarov et al., 2007)or wild-type or
mutant tau(Zhang et al., 2004) display axonal transport deficits and axonal
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swelling. Amyloid plaques are composed of deposits of the amyloid-!-peptide,
which is produced by cleavage of the APP by !-secretase and "-secretase, a
multi-subunit protein complex in which PS1 or PS2 is the catalytic subunit.
A recent study showed that Prickle, a mutation of which results in epileptic
phenotypes observed in flies, mice, zebrafish, and humans, organizes
microtubule polarity and influences both anterograde and retrograde vesicle
transport in axons of Drosophila neurons. The seizure phenotype in prickle
mutant flies is caused by enhancement of the anterograde transport. Additionally,
they showed Prickle heterozygotes exhibit severely reduced vesicle transport,
with loss of both alleles of Prickle showing a marked decrease in
viability(Ehaideb et al., 2014). This is the first link between defective axon
transport and seizures.
Although to date no links between Lis1 and Nudel have been proposed in
ALS, huntington’s disease or other neurological disorders, our demonstration that
both proteins play a role in retrograde axon transport of lysosomes and
mitochondria in mature neurons, coupled with the continued expression in mature
brains, suggests this possibility should not be ruled out, and loss of Lis1 postdevelpmentally could result in neurological disorders.
We have generated an inducible Lis1 knockout mouse as described in
Chapter 1. In this study, we first analyzed the behavioral consequences of loss of
Lis1 post-developmentally in adult mice, given the evidence that Lis1 plays
essential roles in many aspects of neuronal development such as neuronal
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migration as well as axonal transport. We also examined cytological
abnormalities that may indicate neuronal dysfunction in knockout animals.

2.2 MATHODS AND MATERIALS

TM injection and Cre activation
To induce Cre-mediated recombination, tamoxifen (Sigma-Aldrich) was dissolved
in corn oil (Sigma-Aldrich) at a concentration of 40mg/ml and administered to 2-5
month-old Lis1fl/fl; CreERTM; R26GT at different dosages (2mg/d for 5days, 4mg/d
for 5days, or 8mg/d for 2days) depending on the experiment settings. Water and
food were available ad libitum. Experiments were performed on 2-5-month-old
male and female littermates after tamoxifen administration. No significant gender
differences were observed.

Tissue preparation and Histology.
Animals were deeply anesthetized with isofluorane administration and perfused
transcardially with ice-cold PBS first, followed by 4% paraformaldhyde (PFA) in
0.1M PBS, pH7.4. For whole-mount organ analysis, organs were isolated and
imaged with a CCD camera mounted on a fluorescence microscope(Olympus).
For cryosection preparation, brains, hearts, lungs, livers and other tissues were
removed and postfixed in 2% PFA+15% sucrose solution prepared in PBS
overnight and subsequently cryoprotected by incubation in 30% sucrose solution
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for 3-4 hours at room temperature. The cryoprotected brains were submerged in
OCT Compound solution and quickly frozen in 2-methylbutane cooled in liquid
nitrogen. Sagittal or coronal sections were cut at a 10-µm thickness on a cryostat
(Leica) and stored at -80oC before used. Slides were washed three times with
PBS, treated with DAPI (Molecular Probes), washed again, mounted in antifade
reagent (Invitrogen) and imaged with fluorescience microscopy (Zeiss) or
confocal microscopy (Leica).

Immunoblotting
The levels of Lis1 protein was evaluated in Lis1 CKO and age-matched control
mice by immunoblotting. Mice were deeply anesthetized and decapitated, and
the brains and other tissues were removed quickly and frozen on dry ice. Tissue
samples were homogenized with Dounce’s homogenizers in ice-cold RIPA buffer
with protease inhibitors . Crude homogenates were sat on ice for 20 minutes and
then centrifuged at 20,000 g for 1 hour (4oC) to yield soluble supernatant and
pellet fractions. Protein concentrations were measured by BCA assay (Thermo
scientific) with bovine serum albumin as a standard. Protein samples were
subjected to 10% SDS-PAGE and transferred to PVMF membrane. Blots were
blocked with 5% nonfact dry milk with 0.1% Tween 20 in PBS and then incubated
overnight at 4oC with antibody to Lis1 or dynein intermediate chain. After the
primary antibody incubation, blots were washed and incubated with horseradish
peroxidate-conjugated secondary antibody, developed with enhanced
chemiluminescence(Millipore) and exposed to x-ray film.
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To quantify protein immunoreactivity, films were scanned and densitometry was
performed using image J. Protein levels were expressed as relative optical
density measurements. Immunodensities were normalized to control proteins.
Quantifying chromatolysis and nuclear eccentricity
Toluidine blue-stained sections were used as part of the structural analysis. A
chromatolytic neuron cell body was taken as one where discrete patches of
cytoplasmic basophilia (Nissl bodies) could no longer be resolved in the light
microscope over more than half the area of the cell body cytoplasm. An eccentric
nucleus was taken to be one where the distance from the center of the nucleus to
the cell body periphery was less than the distance from the center of the nucleus
to the center of the cell body.

Primary mouse dorsal root ganglion (DRG) culture
Primary DRG neuronal cultures were prepared based on the modified protocol for
rat DRG culture. Mice were first perfused with sterile ice-old PBS to remove
blood and proteases so that nerves can be easily pulled out. Removed the bones
surrounds spinal cord and pull out dorsal roots. Dissected out Lumbar 5-6 DRGs
and dissociated ganglions in Collagenase for 1 hour, followed by 15 minutes with
0.05% trypsin (Invitrogen). Dissociated neurons were spinned through a 15%
sucrose solution. Neurons were plated onto sterile german glass coverslips
(Fisher) coated with 10µg/ml poly-D-lysine (Sigma) and 10µg/ml laminin
(Millipore).
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Immunostaining
Neurons were plated onto 12mm coverslips in 24-well plates. Neurons were fixed
in 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100 for
5 min at room temperature. Nuclei were visualized with Hoechst and
coverslipswere mounted on glass slides using ProLong Gold Antiface reagent
(Invitrogen). Neurons were observed using an inverted microscope (Axiovert 200,
Carl Zeiss Inc.) equipped with Plan-Neo 100x/1.30 objective and a Plan-Apo
63X/1.40 objective. Digital images were acquired using a charge-couple camera (
AxioCam HRm, Carl Zeiss Inc.) linked to AxioVision software (Version 4.7, Carl
Zeiss Inc.).

Fluorescence time-lapse microscopy
After exposure to 100nM Lysotracker for 20minutes, coverslips were transferred
into fresh medium containing 25mM Hepes, pH7.4, in a water-heated custombuilt microscope stage warmed to 37oC using an inverted microscope (Axiovert
200,Carl Zeiss Inc.) equipped with C-Apo 63x/1.2 W/0.2 water-immersion
objective. Digital images were acquired using a charge-coupled camera
(AxioCam HRm, Carl Zeiss Inc.) linked to AxioVision software (version 4.7, Carl
Zeiss Inc.). For tracking lysosomes labeled with Lysotracker-Red (Millipore Inc.)
in axons, images were recorded for 2min at 0.5 second intervals. Each
experiment was done three times with different DRG sensory neuron cultures.
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Analysis of organelle movement using Image J software
To determine the proportion of organelles that moved in different directions or
remained static, kymographs were generated from time-laspe movies using
image J software (version 10.2) as described in miller and Sheetz,2006 (Miller
and Sheetz, 2006). By convention the direction towards the cell body was always
to the right, so lines that sloped toward the right at any point with a net
displacement of >5µm were categorized as retrograde organelles. Lines that
sloped toward the left >5µm at any time during the recording interval were
considered anterograde organelles. Lines that showed less then 5µm lateral
displacement in any direction during the recording interval were categorized as
static.

Statistical analysis
Microsoft Exel and GraphPad Prism software was used for all statistical analysis.
A Student’s unpaired, two-tailed t-test, ANOVA or Turkey’s multiple comparison
test were used to calculate P values for all datasets. Single standard errors
(s.e.m) are shown as bars on each graph.

2.3 RESULTS:
Tamoxifen inducible actin-Cre-mediated knockout of Lis1 in adult mice
causes a progressive decline and death as early as second day after
tamoxifen injection
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In order to induce Cre activation in adult mice, high dose of tamoxifen
(8mg/day for two consecutive days) was administrated on the animals to ensure
high recombination efficiency (Table 2.1). Adult triple mutant mice at 8-week old
injected on two consecutive days with tamoxifen began to exhibit malaise on as
early as the second day, with clearly ruffled coats and spinal kyphosis(Figure
2.1A). They were hypoactive and exhibited leg clasping in tail suspension test. In
the initial studies experimental animals died on day 3-5 after the first injection
(n=11). Control mice without Cre with same amount of tamoxifen injection
showed no signs of distress at any time, nor did the mock-injected experimental
animals (n=10). In later studies, animals were euthanized on day 3-5 for tissue
analysis, and to examine GFP and Lis1 expression in various tissues (n=21).
Older mice (2-5 months) injected with the same amount of tamoxifen (8mg/day
for 2 days) showed the same behavior changes and died within one week after
initial tamoxifen injection (n=3). Older mice tend to exhibit severe malaise at later
days compared to younger mice probably due to older mice weigh slightly more
than young ones, thus the overal exposure to tamoxifen is less in older mice. In
order to determine whether Cre activation by tamoxifen has effect on the
observed phenotype, controls without floxed Lis1 (CreERTM;R26GT) injected with
the amount of tamoxifen were examined and found to be normal, suggesting Cre
activation itself does not cause adverse effects in mice (n=24).
Similarly, lower dose of tamoxifen was also administered on adult mice to
drive cre activation(Table 2.2). Adult triple mutant mice (8-week old) injected with
2mg tamoxifen per day for 5 consecutive days did not exhibit apparent behavior
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changes until day 5 and die eventually between day 9 -16(n=6)(Figure 2.1B). The
slight difference in survival days is resulted from dose-dependent cre
recombination as it is reported that 3mg tamoxifen leads to 50% cells undergoing
a recombination event 24 h post injection while 9mg of TM results in up to 80% of
cells within a tissue underwent recombination within 24h of TM injection. In total,
35 experimental animals injected with tamoxifen died on day 3-7 or showed very
severe malaise between days 3 and 5. Of 52 total control animals, none showed
signs of malaise. In later experiments, high dose of tamoxifen (8mgx2) was used
to induce Cre activation to ensure high percentage of Cre recombination in mice,
unless noted in the experiments.

Cre activity is not uniformly stimulated in all regions of the brain, and is
highest in the brainstem.
The sudden death of these animals was unexpected, but suggested that
either a vital brain function, or a vital function carried out by other organs, was
perturbed by Lis1 knockout. It was therefore critically important to determine
where Cre was activated at 3-5 days after tamoxifen injection. Examination of
green fluorescence of whole brains from perfused animals indicated that Cre was
strongly active in the brainstem, and cerebellum(Figure 2.2). Much less GFP was
apparent in the cerebral hemispheres at 3 days after tamoxifen. An adult triple
mutant mouse with mock injection showed no green fluorescence background
under the same exposure time. Brain from inducible Lis1 knockout mice injected
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with high dose tamoxifen and sacrificed on 5th day showed stronger GFP in
brainstem and cerebellum than it was injected with low dose tamoxifen and
euthanized on the same day(Figure 2.3). No significant green fluorescence
except a few cells were observed in cortex in high dose tamoxifen treated
animals at 5 days after initial injection.
This indicated that we could not easily ascribe the death of knock out mice
to cortical malfunction due to Lis1 loss, although this remains formally possible if
a knocking out Lis1 in a few cells could lead to death. However, the loss of Lis1
in brainstem, known to be the seat of nuclei controlling to complex
cardiorespiratory network, remained a distinct possibility. Saggital sections of an
inducible Lis1 knockout brain revealed significant amounts of GFP were present
in brainstem and midbrain(Figure 2.4 A,B). Scattered green cells were observed
in cortex and cerebellum under low magnification. Activated fibers and axon
projections were seen at pons under higher magnification(Figure 2.4 C,D). In
order to determine whether and where neuronal cell bodies were activated in the
brainstem, coronal sections of brains were used to identify the positions of
activated neurons in these animals(Figure 2.4E). Confocal imaging of brainstem
sections revealed that significant amounts of GFP were present in what appeared
to be neurons in the brainstem(Figure2.4J), and also in neuropil and many fiber
tracts, including cranial nerves(Figure 2.4F,H,I). Thus, it was likely that Cre was
activated by tamoxifen in neurons that are located in cardiorespiratory control
network. Analysis of tissue sections demonstrated that some astrocytes in the
cortex and hippocampus and Bergman's glia in the cerebellum also expressed
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GFP. These observations are generally consistent with original findings of
R26GT mice, however, due to relative short period between Cre induction and
analysis, Cre recombination by tamoxifen has not occurred in the majority of the
cortex during the 2-day period. It is reported that cell bodies were less
prominently labeled compared to cells expressing cytosolic EGFP in
brain(Muzumdar et al., 2007).
Lis1 expression level is reduced in brainstem of inducible Lis1 knockout
mice
To test whether Lis1 level is reduced in brain tissues of adult triple mutant
animals upon tamoxifen injection, extracts of brainstem, cerebellum, and cortex
from tamoxifen treated of both floxed Lis1 with Cre transgene and floxed Lis1
without Cre mice were probed with polyclonal Lis1 antibody. Brain tissues were
collected at 3 days after high dose tamoxifen injection. Lis1 expression level was
found to be significant reduced in brainstems of floxed Lis1 with Cre animals
compared to controls(Figure 2.5 A). No reduction of Lis1 levels in the cortex was
detected from tamoxifen induced Lis1 knockouts at 3 days after initiation of
treatment compared to floxed Lis1 without Cre. The changes of Lis1 levels in
different brain parts are consistent with Cre activity indicated by the amount of
GFP observed in tamoxifen treated Lis1 knockouts. As stated before, low dose
tamoxifen treated experimental animals did not exhibit severe behavior
abnormality until 7 days after initial treatment. We wanted to compare Lis1
expression patterns in high dose tamoxifen treated Lis1 knockouts and low dose
treated animals. Experimental and control mice induced with both doses of
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tamoxifen were sacrificed on 5th day after the first injection and brain tissues were
harvested on the same time point. Western blot demonstrated that Lis1
expression level had not reduced on 5th day after low dose tamoxifen injection,
while its level dramatically decreased at the same time point in high dose treated
experimental animals(Figure 2.5B). Fluorescence images of low dose treated
Lis1 knockout brains showed weak GFP in brainstem at 5 day after initial
treatment(Figure 2.3H), while no significant reduction in Lis1 level was detected
in brainstem at the same time point. This observation suggests that there is a
latency between visualization of Cre activation by GFP and the actual Lis1
protein knockdown.

Examination of brain sections for hallmarks of chromatolysis.
To determine the cytopathology associated with behavior abnormalities
and regional Lis1 expression knockdown in brainstem in the inducible Lis1
knockout mice, the brains from experimental and control mice were examined by
Nissl staining. As we have seen Cre activity in axonal projections and neuropil in
brainstem of animals treated with tamoxifen, we hypothesized that if lis1
disruption causes axonal defects in brains, we were likely to detect
neuropathology in the regions that had Lis1 reduction. Axon damage provokes a
process termed chromatolysis, characterized by somal swelling, nuclear
eccentricity, and reduced Nissl substance (ER and ribosomes). This response
may be caused by the disruption of retrograde signaling. Touidine blue staining
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was used to visualize somal swelling, nuclear position, and Nissl substance
dispersal in brain tissue(Figure 2.6A). A Nissl body can be defined as any
aggregate of ribosome ER that could be identified in the light microscope as a
patch in the cytoplasm of Toluidine Blue-stained sections (Johnson et al., 1985).
Brainstem sections were selected where nucleus ambiguus was present in the
coronal sections according to the mouse brain atlas. Landmarks such as fourth
ventricle and pyramus granular layers were used to identify the proper sections.
Comparison were made from matched sections. Neurons were selected in the
regions of nucleus ambiguus, and were scored as having nuclear eccentricity if
the perpendicular distance from the NE to the somal edge at any point is less
than half the perpendicular distance of the NE to the somal edge at any other
point. We measured the ratios of nuclear to soma in inducible Lis1 knockout and
control mice and found that experimental mice harboring floxed Lis1and Cre
transgenes, had significant larger nucleus versus cytoplasm in brainstem (Figure
2.6C). The ratio of nuclear area versus soma was ~0.5 in tamoxifen induced Lis1
knockout (+Cre) compared to the ratio of ~0.2 in control mice (-Cre). Another
conspicuous feature of tamoxifen treated experimental mice, was that nucleus of
neurons in were displaced toward the periphery of the soma and the Nissl
substance was significant reduced in the soma. We then quantified the
percentage of nuclear accentricity based on the criteria described above.
Tamoxifen induced Lis1 knockout mice showed as high as 40 percent of neurons
having nuclear accentricity, while control mice had very few neurons (10%)
showing the same feature(Figure 2.6D).
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Cultured DRG neurons from adult tamoxifen injected experimental animals,
but not controls, show signs of axon pathology and transport defects.
Because of the strong physical and functional link between Lis1 and the
molecular motor protein cytoplasmic dynein, we considered the possibility that
Cre activation and subsequent Lis1 loss would result in axon transport
perturbations. It is difficult to directly measure transport in the brainstem, so we
turned to a culture system that we have used in the past to measure dyneindependent axon transport. Unlike most adult neurons, DRG neurons can be
successfully removed from adult rats and maintained in tissue culture for long
periods of time. These neurons extend only axon like processes with polarized
microtubules so that retrograde transport is typically thought to be carried out by
dynein. On the third day (the day after the 2nd tamoxifen injection) neurons were
removed from experimental triple mutants and control animals (no Cre-ER allele)
and plated onto laminin-coated coverslips. Only the experimental animals
showed GFP fluorescence, while only mTomato fluorescence was detected in
control cells(Figure 2.7A). After 24 hours, cultures were fixed and axons
examined for morphological changes. Several differences were found between
GFP positive axons in from floxed Lis1 animals and Tomato positive axons from
floxed Lis1 animals with no Cre. First the length of axon segments between
branch points was shorter for GFP axons were shorter(Figure 2.7B). Second
there was an increase in the number of varicosities per branch point, and an
overall increase in varicosities per mm of axon(Figure 2.7C,D). Varicosities were
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often seen at axonal ends, indicating defects in axon transport.These swelling
are hallmarks of motor protein disruption in Drosophila and have been
documented in the corpus collosum of mice believed to have defects in axon
transport (Stokin et al., 2005). Therefore, it would be interesting to examine
whether axon transport was defective in tamoxifen induced Lis1 knockouts. To do
so, DRGs were isolated from adult triple mutant and CreERTM;R26GT control mice
at 3 days following tamoxifen injection. DRGs were allowed to grow on laminincoated coverslips for another 24 hours. Lysotracker Red was added to the culture
30min before live cell imaging. Membrane associated tomato fluorescence was
almost gone 3 days after initial treatment. Axon processes can be visualized by
GFP labeling via Cre activation. Lysotracker Red has strong red fluorescence
that allows us to detect acidic organelles in axons. Time-laspe images were
taken at 0.5s interval for 2 min. Kymographs were generated with Image J
software(Figure 2.8A,B). Mice with floxed Lis1 and Cre showed significant
reduction in percentage of acidic organelles undergoing retrograde transport
compared to mice with wild-type Lis1, while there is no significant difference in
anterograde transport with Lis1 perturbation(Figure 2.8C,D,E). The results are
consistent with previous study using adult rat DRGs transfected with Lis1 RNAi in
culture.
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Tamoxifen inducible heterozygous Lis1 knockout mice do not show
apparent behavior abnormality.
Tamoxifen induced knockout double Lis1 alleles leads to progressive
decline and ultimate death in adult mice. We asked whether conditionally
knockout single copy of Lis1 in adult mice would result in different pathological
consequences than double knockouts using floxed-lis1 and actin-Cre strains.
Similarly, adult heterozygous inducible Lis1 knockout and control mice
(heterozygous floxed Lis1 without Cre) were injected with 8mg tamoxifen for 2
constitutive days. Heterozygous Lis1fl/+;CreERTM;R26GT mice did not exhibit
apparent behavior abnormality. This is not surprising as conventional Lis +/- has
much milder phenotype than homozygous Lis1 knockouts. What is interesting to
us, is that analysis of Cre activity in brain tissues of these animals demonstrated
homogenous strong GFP signal in the whole brain, coupled with dramatically
reduced red fluorescence(Figure 2.9). We then did a time-course analysis of Cre
activation in brains. Three heterozygous inducible Lis1 knockouts were injected
with high dose tamoxifen on the same day and were sacrificed individually on day
2,day 7, and day 21 after initial treatment. In a preliminary study, saggital
sections of brains from three animals revealed a gradual increase in the amount
of GFP throughout the brain including cortex, cerebellum and brainstem(
2.10).

43

DISCUSSION:
Our study of the inducible Lis1 knockout mouse model demonstrates the
importance of Lis1 in adult mammals. Tamoxifen induced Lis1 knockout using !actin Cre recombination system causes rapid death in adult mice. It is by far the
first mouse model that studies the pathological consequences of loss of both
alleles of Lis1 knockout in adult system. Although it is rather difficult to pin down
the pathological causes of the lethal phenotype observed in tamoxifen induced
Lis1 knockouts, we have provided several evidences that may be related to
neuronal malfunction of cardiorespiratory control network in brainstem.
The death phenotype observed in tamoxifen induced Lis1 knockout mouse
model is very consistent. Despite of difference in survival days, all the
experimental mice showed sickness, underwent progressive decline and ultimate
death, if not euthanized. Adult tamoxifen induced Lis1 knockout mice also
exhibited ruffled up fur, hunched posture and leg clasping, indicating impaired
locomotion and bad coordination(Connert et al., 2006). However, these severely
and progressively disturbed neuromotoric functions were accompanied with the
appearance of sings of illness and physical abnormalities observed in tamoxifen
induced Lis1 knockout mice. It is possible that disturbed behavior is an indirect
result of getting sicker and weaker rather than a direct consequence of loss of
Lis1.
Examination of Cre activity in the brains of tamoxifen induced Lis1
knockout mice revealed highest level of GFP expression in brainstem. The loss
of Lis1 in brainstem becomes a possible cause of the lethal phenotype. The pre44

Botzinger complex has been identified to be regulating the medullary respiratory
network in mammals(Schwarzacher et al., 2011). The presumed pre-Botzinger
complex is characterized by an aggregation of loosely scattered, small and
lipofuscin-rich neurons, which contain neurokinin 1 receptor as well as
somatostatin. The pathoanatomical studies support the view that disruption of the
central respiratory network, including the pre-Botzinger complex, contributes to
breathing disorders in multiple system atrophy such as Rett syndrome(WeeseMayer et al., 2006). A study revealed that selective lesions of the nucleus tractus
solitarii lead to altered baroreflex control and to cardiac changes that may lead to
sudden death(Talman and Lin, 2013). Acute stroke can disturb central
autonomic control, resulting in cardiac arrhythmias and ultimately sudden death.
Evidence suggests that sudden deaths are probably due to an interaction
between cardiovascular and neurological causes(Soros and Hachinski, 2012).
There are other possible neurological explanations for the death
phenotype. For example, disruption of Lis1 in myelinating cells could alter
neurotransmission. Acute-onset chronic inflammatory demyelinating
polyradiculoneuropathy (A-CIDP) features multiple cranial nerve involvement,
respiratory failure and skin manifestations(Hantson et al., 2010). Mutation in the
tumor-suppressor phsophatase with tensin homology (PTEN) is associated with
neurological abnormalities including autism, seizures and ataxia(Fraser et al.,
2004; Wei et al., 2006). Pten-deficient neurons in Pten conditional knockout mice
revealed enlarged abnormal synaptic strucutres in the cerebral cortex and
cerebellum. Severe myelination defects and weakened synaptic transmission
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were observed in these mice(Fraser et al., 2008). Thus, it is possible that loss of
lis1 causes defective myelination in cranial nerve, which results in impaired
synaptic transmission in the cardiorespiratory control center. Cerebellar cells
could also be involved in this network.
Astrocytes have been thought to be required for efficient functioning of
respiratory neuronal network activity. Astrocytes have been reported to control
breathing through pH-dependent release of ATP(Gourine et al., 2010). Cre
activity detected in astrocytes in cortex suggests that loss of Lis1 in these cells
may influence the homeostasis of the extracellular space that interfere with Ca+
concentration and neurotransmitter release.
In addition, we found that Lis1fl/fl;actinCreERTM;R26GT neurons in the
brainstem region showed axonal pathology at 3 days following tamoxifen
injection. There is a concern that we may have seen magnocellular neurons
(large in diameter and spindle-shaped) in one brain section, while paraventricular
neurons(small diameter and round-shaped) seen in the other section (Bader et
al., 2012). However, note that in the chromatolysis analysis, the neurons we
selected had similar size in diameter (Figure 2.6E). Brainstem neurons display a
prominent chromatolysis reaction, which is typical of axon injury(Hanz and
Fainzilber, 2006). The RNA content and rate of protein production in cell bodies
increase in response to axonal injury(Cragg, 1970; Lieberman, 1971). The
proposed mechanism is that the rapid ion influx at the injury site generates a
number of electrophysiological response and the normal supply of retrogradely
transported molecules such as trophic factor signals was interrupted. The
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continuous supply of neurotrophic factors from axon terminals to the cell body is
critical in maintenance and survival of specific populations of adult neurons (Hanz
and Fainzilber, 2006). Recent studies indicate that in ALS, degeneration of
motoneuron cell body is late in comparison to degeneration of axons. In the
“acute” ALS group, enlargement of the tigroid has been occurring earlier than
central chromatolysis. This phenomenon may be related to endoplasmic
reticulum stress, disturbed axon transport or functional compensation of the
neuronal deficit(Dziewulska et al., 2013). Thus, the chromatolysis occurring in the
brainstem neurons from tamoxifen induced Lis1 knockout mouse suggests that
axon damage or defects in axon transport has occurred in the brainstem of these
mice.
Our results confirm that reduction of Lis1 in adult neuron causes axonal
pathology and defective axon transport. We found that there was an overall
increase in varicosities per mm of axon. Mice with floxed Lis1 and Cre showed
significant reduction in percentage of acidic organelles undergoing retrograde
transport compared to the control mice. Axonal defects have been noted in
mouse model of Alzheimer’s disease. Similar axonal defects in the early stages
of Alzheimer’s disease have also been seen in humans. It is reported that axonal
swellings are consisted of accumulated abnormal amounts of microtubuleassociated and motor proteins, organelles, and vesicles. It is shown that
reduction of kinesin motor protein impaired axonal transport, enhanced the
frequency of axonal defects and increased amyloid-! peptide levels and amyloid
deposition(Stokin et al., 2005). There is also evidence showing defective axon
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transport of mitochondira, abnormal mitochondrial dynamic and synaptic
degeneration in a mouse model of Alzheimer’s disease(Calkins et al., 2011). ALS
is a fetal neurodegenerative disease, characterized by the loss of motor neurons
in primary motor cortex, the brainstem, and the spinal cord, causing devastated
basic, fundamental movements, such as breathing, and typically causes death in
most cases(Kim et al., 2014). Deficit in axonal transport is a key pathogenic
event in ALS and an early disease indicator of motor neuron
degeneration(Bilsland et al., 2010). Brainstem is consisted of several types of
motor neurons that are responsible for breathing and heart beating. Axonal
defects we have seen in the brainstem and cultured DRG neurons of tamoxifen
induced Lis1 knockout mice may indicate that the motor neurons in the brainstem
undergo neurodegeneration due to Lis1 loss, which leads to neuronal misfunction.
Another possibility we have not examined in these mice is defects in synapse
transmission. We could concevably look at synapses by electronic microscopy or
immunofluorescence.
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Table 2.1 Characterization of phenotypes of inducible Lis1 knockout mice
upon high dose tamoxifen injection.

Genotype

8 mg
x2 TM
+

fl/fl

Lis1
actCreERTM
R26GT
Lis1fl/fl
R26GT
actCreERTM
R26GT

+

Phenotype
dead within
1 week
Sick and
euthanized
by endpoint

Age at injection (months)
Total

<2

2-3

3-5

>5

2/2

9/9

3/3

ND

2/2

8/8

8/8

3/3

21/21

14/14

-

dead or sick

ND

0/3

0/5

0/2

0/10

+

dead or sick

0/2

0/7

0/12

0/3

0/24

+

Sick and
euthanized
by endpoint

0/8

0/13

0/5

ND

0/26
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Table 2.2 Characterization of phenotypes of inducible Lis1 knockout mice
upon low dose tamoxifen injection.

2 mg x 5
TX

Phenotype

2-3 month

+

Dead within 3
weeks

3/3

+

Sick and euthanized
by endpoint

3/3

-

normal

3/3

Lis1fl/fl
R26GT

+

normal

3/3

actCreERTM
R26GT

+

normal

ND

Genotype

Lis1fl/fl
actCreERTM
R26GT
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B.

Figure 2.1 Survival analysis of tamoxifen induced Lis1 knockout mice. A)
Adult triple mutant mice at 8-week old injected on two consecutive days with
tamoxifen (+Cre+TM) began to exhibit malaise on as early as the second day,
with clearly ruffled coats and spinal kyphosis. They were hypoactive and did not
respond to external stimuli. Control mice (-Cre+TM) showed wild type
phenotypes. B) Kaplan-Meier survival curves showing cumulative morbidity percentage of mice showing sickness. In the initial studies experimental animals
injected high dose tamoxifen (+Cre+8mgx2 TM) started showing sickness at day
2 following the first injection (n=30). Experimental mice injected with low dose
tamoxifen (+Cre+2mgx5 TM) did not exhibit apparent behavior changes until day
5 (n=10). Control animals (-Cre) injected with tamoxifen did not show any signs
of malaise or behavior abnormality (n=31). Log-rank Test *** P<0.001
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Figure 2.2 High dose tamoxifen induced Cre activation in brainstem at 3
days following initial treatment. A,B)Whole mount images of control mice
Lis1fl/fl;R26GT) injected with 8mg tamoxifen for 2 consecutive days showed strong
red fluorescence. C,D) with no GFP expression in the brain. G,H) Examination of
green fluorescence of whole brains from perfused animals indicated that Cre was
strongly active in the brainstem, and cerebellum(under the same exposure time
as controls. Much less GFP was apparent in the cerebral hemispheres at 3 days
after tamoxifen. E,F) Residual red fluorescence was shown in the images.
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Figure 2.3 High dose and low dose tamoxifen induced Cre activation in
brainstem at 5 days following initial treatment. A,B) An adult triple mutant
mouse with vehicle injection(+Cre+vehicle) showed no green fluorescence
background. C,D) The brain from an inducible Lis1 knockout mouse injected with
high dose tamoxifen and sacrificed on 5th day showed strong GFP in brainstem
and cerebellum. A few green cells were also detected in the cortex. Red
fluorescence was greatly reduced in brainstem and cerebellum and remained
high in cortex. E,F) Control brain( -Cre+2mgx5 TM) showed strong red
fluorescence but no GFP expression. G,H) Low dose tamoxifen treated
experimental animal (+Cre+2mgx5 TM) exhibited relatively low amount of GFP
expression in brainstem and cerebellum at 5 days following initial treatment.
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Figure 2.4 Cre activities were detected in cardiorespiratory control network
in tamoxifen induced Lis1 knockout mice. A,B) Saggital sections of an
inducible Lis1 knockout brain revealed significant amounts of GFP were present
in brainstem and midbrain. Scattered green cells were observed in cortex and
cerebellum under low magnification.(n=1) C,D) Activated fibers and axon
projections were seen at pons under higher magnification(x40).(n=1) E) Coronal
sections of brains identified the positions of activated neurons in these
animals.(n=4) F) Confocal imaging of brainstem sections revealed that significant
amounts of GFP were present in neurons in the brainstem, and also in neuropil
and many fiber tracts. G) Diagram of a saggital brain section showing different
regions. H, I) Cre activity was also detected in cranial nerves.(n=1)
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Figure 2.4 J Coronal sections of brainstems from tamoxifen induced Lis1
knockout mice. Brains were harvested from 4% paraformaldehyde perfused
animals. Tissues were embedded in OCT and sectioned using cryostat. 10µm
thick sections were collected and mounted on gelatin-coated slides. Images were
taken by a dissecting scope attached with a CCD camera. Images show GFP
expression in brainstems at 3-5 days following Cre induction by tamoxifen.

55

B.

A.

C.

Figure 2.5 Lis1 expression level is reduced in brainstem of inducible Lis1
knockout mice. A.) Extracts of brainstem, cerebellum, and cortex from
tamoxifen treated of both floxed Lis1 with Cre transgene and floxed Lis1 without
Cre mice were probed with polyclonal Lis1 antibody. Brain tissues were collected
at 3 days following high dose tamoxifen injection. Lis1 expression level was
found reduced in brainstems of floxed Lis1 with Cre animals compared to
controls. No reduction of Lis1 levels in the cortex was detected from tamoxifen
induced Lis1 knockouts at 2 days after initiation of treatment compared to floxed
Lis1 without Cre. No difference of dynein expression level was detected in
tamoxifen induced Lis1 knockout lysates compared to control ones. B.) Cortex,
cerebellum and brain stem of experimental animal were collected at Day 5
following tamoxifen treatment. Lis1 expression level was found reduced in
brainstems and cerebellum of floxed Lis1 with Cre animals compared to controls.
No difference of dynein expression level was detected in tamoxifen induced Lis1
knockout lysates compared to control ones. C.) Quantification of Lis1
expressions in the cortex, cerebellum, and brainstem from 4 animals of each
genotype. Values are mean±SD. ** P<0.01, student t-test.
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Figure 2.6 Lis1fl/fl;actCreERTM;R26GT neurons in the regions of the nucleus
ambiguous show axonal pathology at 3 days following tamoxifen injection.
A.) Toluidine blue staining showed somal swelling, nuclear position, and Nissl
substance dispersal in brain tissue. In tamoxifen treated experimental mice,
nucleus of neurons in was displaced toward the periphery of the soma and the
Nissl substance was significant reduced in the soma (thick arrows) . Brainstem
sections were selected where nucleus ambiguus was present according to the
mouse brain atlas. Comparison were made from matched sections. B.) Diagram
shows a coronal section of mouse brain. The region analyzed was reticular
formation where contain nucleus ambiguus. C.) Quantification of nuclear
area/soma area in inducible Lis1 knockout mice and control mice. Neurons were
scored as having nuclear eccentricity if the perpendicular distance from the NE to
the somal edge at any point is less than half the perpendicular distance of the NE
to the somal edge at any other point. Experimental mice had significant larger
nucleus versus cytoplasm in brainstem. Measurements were from 50 neurons
from 3 sections of 2 mice per genotype. Values are mean±SD. ***P<0.0001,
student t-test D.) Quantification of the percentage of nuclear eccentricity
observed in tamoxifen inducible Lis1 knockout mice and control mice.
Measurements were from 50 neurons from 3 sections of 2 mice per genotype.
P=0.0043, student t-test.
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Figure 2.6 Lis1fl/fl;actCreERTM;R26GT neurons in the regions of the nucleus
ambiguous show axonal pathology at 3 days following tamoxifen injection.
E.) High magnification images of brainstem neurons from tamoxifen inducible
Lis1 knockout mice and control mice. Scale bar=10µm
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Figure 2.7 Cultured DRG neurons from adult tamoxifen injected
experimental animals, but not controls, show signs of axon pathology A.)
Experimental animals showed GFP fluorescence after Cre induction, while only
mTomato fluorescence was detected in control cells. Varicosities(large axon
swellings at growth cones and axon terminal ends) were seen in the tamoxifen
induced DRGs (white arrows). B) Several differences were found between GFP
positive axons in from floxed Lis1 animals and Tomato positive axons from floxed
Lis1 animals with no Cre. First the length of axon segments between branch
points was shorter for GFP axons were shorter. Branch points were defined as a
segment of axon between two adjacent growth cones. The first branch was
counted from a leading process emerging from the cell body. C) There was an
increase in the number of varicosities per branch point, and D) There is an
overall increase in varicosities per mm of axon. Measurements were collected
from 32 branches from 19 neurons of Lis1 knockouts and 30 branches from 9
neurons of the control. Values are mean±SD. **p=0.0054, ***p<0.001,student ttest.
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Figure 2.7 E.) Representative images of axon varicosities seen in inducible Lis1
knockout and control mice. Much smaller swellings were seen in control
neurons(short arrow). Only large swellings were counted as varicosities(long
arrow). Scale bar=20µm.
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Figure 2.8 Lisfl/fl;actCreERTM;R26GT DRG neurons placed in culture after
tamoxifen treatment show defective axonal transport. A,B) Retrograde
transport was disrupted in mice with floxed Lis1 and Cre compared to mice with
wild-type Lis1. C,D,E)There is significant reduction in percentage of acidic
organelles undergoing retrograde transport compared to mice with wild-type Lis1,
while there is no significant difference in anterograde transport with Lis1
perturbation. Measurements were collected from 24 axons of 3 sets of animals
per genotype. Anter: the numbers of organelles that moved toward the cell body,
Retro: away from the cell body, Both: bi-directionally, Static: made negligible
moves in either direction.Values are mean±SD. Turkey’s multiple comparison test
was performed. ***p<0.001
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Figure 2.8 Lisfl/fl;actCreERTM;R26GT DRG neurons placed in culture after
tamoxifen treatment show defective axonal transport. F.) Representitive
images of kymographs showing transport data in mice with floxed Lis1 and
without floxed Lis1.
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Figure 2.9 Heterozygous Lis1fl/+;CreERTM;R26GT mice did not exhibit
apparent behavior abnormality. Analysis of Cre activity in brain tissues of these
animals demonstrated homogenous strong GFP signal in the whole brain,
coupled with dramatically reduced red fluorescence.
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Figure 2.10 Time-course analysis of Cre activation in brains. Three
heterozygous inducible Lis1 knockouts were injected with high dose tamoxifen on
the same day and were sacrificed individually on day 7, and day 21 after initial
treatment. Saggital sections of brains from three animals revealed a gradual
increase in the amount of GFP throughout the brain including cortex, cerebellum
and brainstem.
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CHAPTER 3

THE EFFECT OF AN INDUCIBLE ACTIN-CRE DOUBLE LIS1 KNOCKOUT IN NONNEURONAL TISSUES AND AN INDUCIBLE MYH6-CRE LIS1 KNOCKOUT MOUSE
MODEL
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3.1 INTRODUCTION：
Analysis of the actin-Cre driven inducible Lis1 knockout in an adult mice
model suggested a previously unidentified but essential role of Lis1 in adult
mammalian system, particularly in maintaining normal neuronal function. We
have identified evidence of correlations between loss of Lis1 in brainstem and
axon defects in tamoxifen induced Lis1 knockout animals. However, whether
reduction of Lis1 expression level and the subsequent neuronal pathology in
cardiorespiratory center in brainstem directly lead to the lethal phenotype
observed in adult mice remains unclear. We could not rule out the possibility that
loss of Lis1 upon Cre activation in other tissues such as hearts, lungs, liver etc
could contribute to the death phenotype in tamoxifen inducible Lis1 knockouts
since !-actin Cre drives Cre expression in most tissues throughout the whole
body. Thus, it would be necessary to examine Cre activity in other tissues
besides brains.
Although Lis1 expression level is very low in non-neuronal tissues,
knockdown of Lis1 in life-threatening organs such as hearts could conceivably
lead to ultimate death phenotype in adult mice. Besides its critical role in
regulating neuronal functions in embryonic brain development, Lis1 is also
involved in regulating other important cell functions. A lot of these regulations
involve the interaction between Lis1 and a microtubule motor, dynein. The levels
of Lis1 alter the distribution of dynein IC in Cos-7 cells and Lis1+/- fibroblasts
exhibit microtubule organization(Smith et al., 2000). Lis1 has also been
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implicated in mitotic spindle orientation and chromosome segregation, defects in
which, in turn, affect mitotic progression (Faulkner et al., 2000). In mammalian
cells, dynein/dynactin recruits Lis1 to kinetochores. Lis1 regulates
dynein/dynactin binding to microtubule (MT)(Coquelle et al., 2002; Tai et al.,
2002). Interaction between Lis1 and dynein heavy chain is important for
membrane transport and possibly other cellular activities(Liang et al., 2004).
Invitro studies showed that Lis1 reduced microtubule catastrophe events, and its
interaction with the cytoskeleton may be transducing a signal pathway(Sapir et al.,
1997). The yeast homologue of Lis1,Pac1p has been shown to interact with a
ubiquitin ligase(Alonso et al., 2012)
To date, there are only a few studies investigating roles of Lis1 in nonneuronal system. The epidermal-specific loss of Lis1 results in dramatic defects
in microtubule reorganization. Lis1 ablation also causes desmosomal defects,
which contributes to loss of epidermal barrier activity, resulting in completely
penetrant perinatal lethality(Sumigray et al., 2011). A most recent study
demonstrated that Lis1 is critically required for hematopoietic stem cell function
and leukemogensis. Conditional deletion of Lis1 in the hematopoietic system led
to a severe bloodless phenotype, and embryonic lethality(Zimdahl et al., 2014).
Conditional deletion of Lis1 in developing hair cells causes defects in cytoplasmic
dynein and microtubule organization, resulting in planar polarity defects without
overt effects(Sipe et al., 2013). Although limited, these observations from Lis1
knockout mouse model suggest that Lis1 disruption in other tissues could result
in defective organ functions.
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Although we do not expect loss of Lis1 in non-neuronal adult tissue would
lead to severe phenotypes given its relatively low expressions, if it does so, it
would be a previously unidentified yet critical role of Lis1 in adult organs besides
the brain.
In this chapter, we examined Cre activity in various tissues in inducible
adult Lis1 knockout mice. Cre activity was found most abundantly in the heart
and skeletal muscle, which are relevant to high expression of !-actin in these
tissues. We also analyzed changes of Lis1 expression levels in multiple tissues
of tamoxifen induced Lis1 knockouts. Significant reduction of Lis1 in adult heart
prompted us to generate an inducible cardiomyocyte- specific Lis1 knockout
mouse model. The alpha-MHC-MerCreMer transgene has the mouse cardiacspecific alpha-myosin heavy chain promoter (Myh6) directing expression of a
tamoxifen-inducible Cre recombinase to adult cardiac myocytes. Mice
homozygous for the Myh6 transgene are viable and fertile prior to tamoxifen
administration. Lexow et al reports that a single tamoxifen injection (40mg
tamoxifen/kg body weight) resulted in th uniform recombination in cardiomyocyte
fibers without the cardiomyopathological effects. (Lexow et al., 2013)One week
following tamoxifen injection, Cre activation detected by scattered !-gal
expression was observed in atria, and homogenous expression in
ventricles(Sohal et al., 2001). Driving Cre expression specifically in the heart
with a MHC-6 promotor did not result in observable behavior abnormality.
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3.2 MATERIALS AND METHODS:
Mouse breeding and colony maintenance
All the mice used in this project were maintained at the animal research facility in
The University of South Carolina. The experimental protocols have been
approved by the animal use protocol (AUP) committee. All the transgenic mice
and knockout mice were maintained on its original genetic background. However,
when generating inducible Lis1 knockout mice by crossing three different mouse
strains, mixed genetic background could not be avoided. To minimize variation in
the genetic background, the males (Lis1fl/fl;myh-6-CreERTM; R26GT) and
famales (Lis1fl/fl;R26GT) from the same generation were crossed to produce
inducible Lis1 knockout mice, and mice from the same litter were compared.
However, in order to gather enough samples for statistical analysis, tissues from
different animals with the same genotype at different ages were pooled.
Mice were marked by ear puncture at weaning (3-4 weeks old), and genomic
DNA was extracted from tail for routine genotyping.

1.2.3 Genotyping:
Primers for genotyping heart-specific Cre are the same as universal Cre. Mice
tails were digested in Tail buffer plus Protease K overnight at 55 oC. 2µl of tail
digest was used as DNA templates for PCR reaction. Primers for Lis1 flox/flox:
Sequence5'->3' TGA ATG CAT CAG AAC CAT GC; CCT CTA CCA CTA AAG
CTT GTT C. Primers for Cre : Sequence5'->3' CTA GGC CAC AGA ATT GAA
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AGA TCT; GTA GGT GGA AAT TCT AGC ATC ATC C. Primers for R26GT :
Sequence5'->3' CTC TGC TGC CTC CTG GCT TCT; CGA GGC GGA TCA CAA
GCA ATA ; TCA ATG GGC GGG GGT CGT.
A standard PCR reaction was set up as followed: For each tail DNA sample, to
make 25µl total volume, 6.5µl of H2O, 5.5 µl Master Mix 2.5µl each primer and
2µl Tail DNA were added to PCR tubes. The reaction was performed on a PCR
thermocycler as follows: 94oC for 3 min for hotstart; 94 oC for 30s, 60 oC for 1
min, 72 oC for 1min. Repeat steps above for 35 cycles. 10µl of the reaction
product was run on 5% polyacrylamide gel at 120V for 30 min. Gel was stained
with EB for 10min. DNA bands could be detected under UV light.

TM injection and Cre activation
We used the same amount of tamoxifen to induce Cre-mediated recombination in
heart specific Lis1 knockout mice as the universal Cre. Tamoxifen (SigmaAldrich) was dissolved in corn oil (Sigma-Aldrich) at a concentration of 40mg/ml
and administered to 2 month-old Lis1fl/fl; myh6-CreERTM; R26GT at 8mg/day for 2
days depending on the experiment settings. Water and food were available ad
libitum.

Tissue preparation and Histology.
Animals were deeply anesthetized with isofluorane administration and perfused
transcardially with ice-cold PBS first, followed by 4% paraformaldhyde (PFA) in
0.1M PBS, pH7.4. For whole-mount organ analysis, organs were isolated and
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imaged with a CCD camera mounted on a fluorescence microscope(Olympus).
For cryosection preparation, brains, hearts, lungs, livers and other tissues were
removed and postfixed in 2% PFA+15% sucrose solution prepared in PBS
overnight and subsequently cryoprotected by incubation in 30% sucrose solution
for 3-4 hours at room temperature. The cryoprotected brains were submerged in
OCT Compound solution and quickly frozen in 2-methylbutane cooled in liquid
nitrogen. Sagittal or coronal sections were cut at a 10-µm thickness on a cryostat
(Leica) and stored at -80oC before used. Slides were washed three times with
PBS, treated with DAPI (Molecular Probes), washed again, mounted in anti-fade
reagent (Invitrogen) and imaged with fluorescence microscopy (Zeiss) or
confocal microscopy (Leica).

Immunoblotting
The levels of Lis1 protein was evaluated in Lis1 CKO and age-matched control
mice by immunoblotting. Mice were deeply anesthetized and decapitated, and
the brains and other tissues were removed quickly and frozen on dry ice. Tissue
samples were homogenized with Dounce’s homogenizers in ice-cold RIPA buffer
with protease inhibitors. Crude homogenates were sat on ice for 20 minutes and
then centrifuged at 20,000 g for 1 hour (4oC) to yield soluble supernatant and
pellet fractions. Protein concentrations were measured by BCA assay (Thermo
scientific) with bovine serum albumin as a standard. Protein samples were
subjected to 10% SDS-PAGE and transferred to PVMF membrane. Blots were
blocked with 5% nonfact dry milk with 0.1% Tween 20 in PBS and then incubated
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overnight at 4oC with antibody to Lis1 or dynein intermediate chain(). After the
primary antibody incubation, blots were washed and incubated with horseradish
peroxidate-conjugated secondary antibody, developed with enhanced
chemiluminescence(Millipore) and exposed to x-ray film.
To quantify protein immunoreactivity, films were scanned and densitometry was
performed using image J. Protein levels were expressed as relative optical
density measurements. Immunodensities were normalized to control proteins.

Immunostaining
Neurons were plated onto 12mm coverslips in 24-well plates. Neurons were fixed
in 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100 for
5 min at room temperature. Nuclei were visualized with Hoechst and coverslips
were mounted on glass slides using ProLong Gold Antiface reagent (Invitrogen).
Neurons were observed using an inverted microscope (Axiovert 200, Carl Zeiss
Inc.) equipped with Plan-Neo 100x/1.30 objective and a Plan-Apo 63X/1.40
objective. Digital images were acquired using a charge-couple camera ( AxioCam
HRm, Carl Zeiss Inc.) linked to AxioVision software (Version 4.7, Carl Zeiss Inc.).
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3.3 RESULTS:
Mosaic Cre activity was detected in non-neuronal tissues of inducible ! actin Cre Lis1 knockout mice
The fluorescent images of whole mount organs showed strongest GFP levels in
heart tissue, while relatively low level of Cre recombination detected in liver at 3
days following tamoxifen injection. At Day 5, an increase in Cre activation
indicated by homogenous green fluorescence detected in the heart and lung, but
GFP level in liver remained low at this point (Figure 3.1). Tissue sections of
tamoxifen induced Lis1 knockout mice revealed a subset of cells were activated
in the heart, lung, liver and kidney(Figure 3.2). These observations are consistent
with the original report of actin-Cre ER mouse model that Cre activities in multiple
tissues were highly mosaic, with the highest recombination efficiency detected in
highly vascular tissue like the heart. The GFP expression patterns detected in
lung, liver and kidney suggest that Cre was activated in a certain type of cells.
Whether these cells have more !-actin expression than others that do not show
green remains unclear. Tissue sections of tamoxifen injected control mice do not
have GFP expression in all organs.

Tamoxifen induced cardiomyocte-specific Lis1 knockout mice do not
exhibit aberrant phenotype
Although there is significantly less Lis1 in these tissues normally, the death of
knock out animals suggested the possibility that Lis1 loss in the heart itself could
result in cardiac failure. To test this directly we crossed our double floxed

73

Lis1/Cre-reporter mice with a mouse in which Cre-ER expression driven by a
myosin heavy chain (MHC6) promoter and is restricted to cardiomyocytes.
Generated heterozygous floxedLis1;myh-6-Cre;R26GT were backcrossed with
double floxed Lis1;R26GT to obtain homozygous floxed Lis1;myh6-Cre;R26GT
mice. Mice harboring double floxed Lis1;R26GT; but no myh-6-Cre served as
control ones(Figure 3.3). Experimental and control mice were injected with 8mg
tamoxifen for two consecutive days. Interestingly, none of the floxed Lis1 animals
showed any overt behavior abnormality following tamoxifen injection (n=6). Lis1
expression level was examined by western blot and found reduced in heart tissue.
Fluorescence images of whole tissue revealed strong GFP expression in cardiac
muscle, with significant red fluorescence reduced. No Cre activation was
observed in the whole brain including brainstem in this heart-specific Lis1
knockout mouse model(Figure 3.4). This strengthened the hypothesis that the
death phenotype was caused by Lis1 loss in neurons of the cardiorespiratory
brainstem network. However, it remains possible that loss of Lis1 in other cell
types in the mouse could contribute to the severe phenotype of Lis1 knockout.

Comparison of Lis1 expression patterns in multiple tissues of low-dose and
high-dose tamoxifen induced Lis1 knockout mice
Analysis of multiple tissue sections revealed that Cre activity was present in
non-neuronal tissues as well as brains. However, the degree of Cre activation
upon tamoxifen injection varies between tissues. Additionally, low-dose tamoxifen
treated Lis1 knockout mice survived longer than high-dose tamoxifen treated
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ones. We know this difference in survival is not due to the direct effect of
tamoxifen as actin-CreERTM;R26GT mice with wild-type Lis1 treated with
tamoxifen do not have detectable behavior abnormality. It may reflect different
changes in Lis1 expression patterns in various tissues, which in turn, may result
in different phenotypes or distinct timings of disease progression in adult mice.
Thus, it would be interesting to compare Lis1 levels in various tissues of low-dose
and high-dose tamoxifen induced Lis1 knockout mice. We compared changes in
Lis1 expression patterns in low-dose and high-dose tamoxifen treated animals.
High dose tamoxifen treated animals showed severe malaise on day 5 following
initial treatment. Low-dose treated animals did not exhibit any behavior
abnormality on day 5. Tissues were collected on day 5 to examine changes of
Lis1 levels. We found that there was a significant reduction in Lis1 level in
brainstem from high-dose treated experimental mice compared to the control,
while low-dose treated animals did not have Lis1 reduction in brainstem on day
5(Figure 3.5). Consistently, there was a Lis1 reduction in tamoxifen treated
hearts in both low dose and high dose cases. However, dynein and tubulin
expression levels were very low in the heart, suggesting Lis1/dynein pathway in
the heart may not be as important as it is in the brain. All of these suggest that
loss of Lis1 in brainstem may be the cause of lethal phenotype observed in
tamoxifen induced Lis1 knockout mice.
High dose tamoxifen treated experimental mice die within one week
following initial injection. Most of them showed severe malaise and were about to
die by the endpoint that we euthanized and harvested the tissue for further
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analysis. Among those, there was one mouse that showed milder phenotype than
other experimental mice. It exhibited leg clasping during tail suspension test,
however, it did not have other symptoms such as kyphosis, difficulties walking
and breathing like other experimental mice did. Low dose tamoxifen treated
experimental mice did not show aberrant phenotype on day 5 following initial
injection. We harvested tissues from the high-dose treated mouse that showed
milder phenotype and compare them to the tissues from the low-dose treated
experimental mice. Tissue lysates were probed with polyclonal Lis1, GFP and
tubulin antibodies. After normalizing to tubulin, western blot showed that there is
a small decrease (~24.7%) in Lis1 in the cortex of high-dose treated animal
compared to the control, while there was no difference in between low-dose
treated animal and the control(Figure 3.6). Interestingly, both in low-dose and
high-dose treated animals, there were dramatic decreases of Lis1 level in hearts.
There was a small reduction in the high-dose treated lung compared to the
control. No difference in tamoxifen treated liver tissues compared to control
livers. These results suggest that reduction of Lis1 level in cortex may result in
behavior abnormality seen in this animal. However, Lis1 reduction in the heart
and the lung did not result in severe phenotype that leads to death observed in
other tamoxifen induced Lis1 knockout mice. GFP expressions in the tamoxifen
induced Lis1 knockout tissues are consistent with fluorescent images of tissue
sections shown earlier, with highest level in hearts.
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Cre activation in diaphragm and skeletal muscle tissues
Heart specific Lis1 knockout mice did not show any obvious behavior
abnormality compared to wild type mice. It suggests that loss of Lis1 in heart
does not cause death phenotype. Other possible causes of lethal problems
include defects in diaphragm that supports regular breathing. Evidence showed
that there was no significant loss of motor neurons or dorsal root ganglia sensory
neurons, but a decrease in complexity of neuromuscular junctions(Courchesne et
al., 2011). We then examined Cre activity in diaphragm and other skeletal
tissues. We detected strong GFP expression in diaphragm and thigh muscle,
which is rich in !-actin(Figure 3.7A). However, Lis1 expression in diaphragm is
almost undetectable compared to its levels in brains and hearts even after
overnight exposure(Figure 3.7 B).

3.3 DISCUSSION:
The pathological causes of the lethal phenotype seen in tamoxifen induced
Lis1 knockout mice are largely unknown. A critical question is whether the
pathological consequences arise from the brainstem neuron itself or from nonneuronal cells. Mosaic Cre activity was detected in non-neuronal tissues of
inducible !-actin Cre Lis1 knockout mice with high level in the heart. Heart failure
is one of the possible reasons that can account for the lethal phenotype.
Tamoxifen induced heart specific Lis1 knockout mice did not exhibit any
observable behavior abnormality as it is seen in the !-actin Cre inducible Lis1
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knockout mice. Given the fact that myh6-Cre only drives Cre activation in
cardiomyctes, we cannot rule out the possibility that loss of Lis1 in other heart
cells such as neural crest cells may affect the phenotype in adult mice.
Additionally, the original myh6-Cre mouse strain is in B6.FVB(129) mixed
background, which may also impact the phenotype observed in these mice.
There is no literature that described the role of Lis1 in heart development so far.
However, there is a link between Lis1 being a target of miR302/367 and lung
development. Lis1 is essential for proliferation and the precise control of mitotic
spindle orientation in both neuroepithelial stem cells and radial glial progenitor
cells (Yamada et al., 2010; Yingling et al., 2008). Downregulation of miR302/367
in transgenic lung endoderm displayed a disorganized apical layer. Lis1 was
found to be associated with miR302/267 for establishment of proper apical-basal
polarity of a single-layered endoderm(Tian et al., 2011). However, again, these
findings are done in the context of developmental stage. No direct link between
Lis1 level and lung function in the adult system has been identified so far.
Western blot analysis of Lis1 levels in various tissues of the tamoxifen
induced Lis1 knockout mouse that had much milder phenotype showed highest
GFP expression level and significant reduction in the heart compared to other
tissues. This suggests that reduction of Lis1 in hearts is not likely to result in the
lethality phenotype observed in !-actin Cre Lis1 knockout mice. We also did
western blot analysis of Lis1 levels in a tamoxifen induced Lis1 knockout mouse
that had severe malaise. It showed that there was a significant reduction of Lis1
in brainstem, while only a slight decrease in other tissues. This preliminary result
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strengthens our hypothesis that the death phenotype is resulted from loss of Lis1
in brainstem. However, due to the technical difficulty of harvesting multiple
tissues from 4 different treatment groups at one time, a more systematic and
detailed tissue analysis will be needed to further confirm the changes of protein
levels in various tissues upon Cre induction. Percentage of Lis1fl/fl;Cre
recombination can also be measured at DNA level using quantitative PCR
amplification of Lis1fl/fl allele from genomic DNA isolated from each tissue.
Alternatively, changes in mRNA level can be used to estimate the recombination
efficiency in various tissues.
The reasons of death phenotype in the inducible Lis1 knockout mouse can
not be certain because !-actin Cre is ubiquitously expressed, and many tissues
can be affected. Another possibility we have not discussed above is respiratory
muscles, like diaphragm. Analysis of Cre activity showed strong GFP expression
in diaphragm and other skeletal muscle. Defects in neuromuscular junction in the
diaphragm could be correlated with breathing defects that may be responsible for
death of the inducible Lis1 knockout mice. However, Lis1 expression in
diaphragm is undetectable compared to it is in the brain and the heart.
Furthermore, low levels of Cre activity were also detected in the liver and kidney
of tamoxifen induced animals. Given the fact that Lis1 plays a important role in
mitosis and dynein-dependent receptor recycling and vesicle transport, loss of
Lis1 in liver and kidney may affect hormone metabolism through signaling.
Although hepatomegaly and edema are not evident, liver and kidney cannot be
excluded.
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Figure 3.1 The fluorescent images of whole mount organs. A,B,C) No green
fluorescence was detected in heart, lung and liver of a control animal(-Cre_
injected with tamoxifen. D,E,F) The fluorescent images of whole mount organs
showed strongest GFP levels in heart tissue, while relatively low level of Cre
recombination detected in liver at 3 days following tamoxifen injection. G,H,I) At
Day 5, an increase in Cre activation indicated by homogenous green
fluorescence detected in the heart and lung, but GFP level in liver remained low
at this point.
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Figure 3.2 Cre activations in various tissue sections. A,B,C,D)Tissue
sections of control mice(-Cre) injected with tamoxifen showed no GFP expression
in heart, lung, liver and kidney. E,F,G,H)Tissue sections of tamoxifen induced
Lis1 knockout mice revealed a subset of cells were activated in the heart, lung,
liver and kidney. Shown are cardiac muscle(E), lung alveoli (F), liver hepatocytes
(G) and kidney glomerulus (H) Scale bar=200µm
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A.

B.

Figure 3.3 Tamoxifen induced cardiomyocyte-specific Lis knockout mice.
A.) Three mouse strains were used to generate cardiomyocyte-specific Lis1
knockout mice. B.) We crossed our double floxed Lis1/Cre-reporter mice with a
mouse in which Cre-ER expression driven by a myosin heavy chain (MHC6)
promoter and is restricted to cardiomyocytes. Generated heterozygous
floxedLis1;myh-6-Cre;R26GT were backcrossed with double floxed Lis1;R26GT to
obtain homozygous floxed Lis1;myh6-Cre;R26GT mice. Mice harboring double
floxed Lis1;R26GT; but no myh-6Cre served as control ones.
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A.

B.

C.

Figure 3.4 Cre activation in cardiomycyte-specific Lis1 knockout mice
A.) Fluorescence images of whole tissue revealed strong GFP expression in
cardiac muscle, with significant red fluorescence reduced. No Cre activation was
observed in the whole brain including brainstem in this heart-specific Lis1
knockout mouse model. B.) Lis1 expression level was examined by western blot
and found reduced in heart tissue. C.) Quantification of Lis1 expressions in the
hearts from 2 animals of each genotype. Values are mean±SD. ** P<0.01,
student t-test.
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A.

B.

Figure 3.5 Changes in Lis1 levels of tissues from low dose and high dose
treated animals. A.) Tissues were collected on day 5 to examine changes of
Lis1 levels. There was a reduction in lis1 level in brainstem from high-dose
treated experimental mice compared to the control, while low-dose treated
animals did not have Lis1 reduction in brainstem on day 5. Consistently, there
was a Lis1 reduction in tamoxifen treated hearts in both low dose and high dose
cases. B.) Quantification of Lis1 expressions in the brainstem and heart from 3
animals of each treatment per genotype. BS: Brainstem, HT: Heart. Low: 2mg
tamoxifen injection per animal. High: 8mg tamoxifen injection per animal. Values
are mean±SD.
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A.

B.

Figure 3.6 Lis1 expression level changes in tissues from low dose and high
dose treated animals. A) There was a small reduction in the high-dose treated
lung compared to the control. No difference in tamoxifen treated liver tissues
compared to control livers. B) Western blot of kidney and diaphragm from lowdose/high-dose tamoxifen treated animals. 30µg protein extracts were loaded on
each lane. There was a reduction of Lis1 in high-dose treated kidney compared
to the control. However, there was no detectable Lis1 present in diaphragm.
Commasse gel staining was used as a loading control.
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A.

B.

C.

Figure 3.7 Cre activities in diaphram and skeletal muscle. A) Strong GFP
expression was detected in diaphragm and thigh muscle, which are rich in !actin. B) Lis1 expression in diaphragm is almost undetectable compared to its
levels in brains and hearts even after overnight exposure. C) Quantification of
Lis1 expressions in the brain, heart and diaphragm from 3 control animals (-Cre).
Values are mean±SD. **P<0.01,***P<0.001. One-way ANONA test.
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CONCLUSIONS AND FUTURE DIRECTIONS
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LIS1 is the gene that encodes for the ! subunit of platelet-activating factor
acetylhydrolase (PAFAH1B1). Heterozygous mutation or deletion in LIS1 causes
a severe developmental brain disorder, lissencephaly in humans. Homozygous
null mice die early in embryogenesis, while mice with one inactive allele
displayed brain disorganization. Moreover, Lis1 has been shown to be regulating
dynein dependent organelle transport. In this study, the effect of Lis1 knockout in
adult mammalian system has been investigated using a tamoxifen inducible
knockout mouse model directed by !-actin Cre. Loss of Lis1 in adult mice caused
a progressive decline and ultimately death. These phenotypes were not observed
in any of a variety of control animals. Analysis of Cre activity revealed it was not
uniformly stimulated in all regions of the brain, and is highest in the brainstem,
where neuronal processes in regions known to control cardiorespiratory networks
were activated. Deletion of lis1 in hearts did not seem to induce lethality or
malaise in adult mice. This strengthened the hypothesis that the death phenotype
may be caused by Lis1 loss in neurons of the cardiorespiratory brainstem
network. Analysis of brain sections and cultured sensory neurons from adult
tamoxifen injected experimental animals revealed axonal pathology and defective
axon transport. However, due to the ubiquitous expression pattern of Cre, we
could not rule out the possibility that loss of Lis1 in non-neuronal tissues may
contribute to the death phenotype observed in tamoxifen induced Lis1 knockout
mice. We have noted that some of the tamoxifen induced Lis1 knockout mice had
wet fur and enlarged abdomen. Whether these symptoms occur frequently still
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needs further examination. This may suggest a bladder and gut dysfunction,
which are components of autonomic functions.
By controlling the site of drug delivery, !-actin Cre allows spatial
modulation of gene activity. In this case, 4-OH tamoxifen can be sterotaxicically
injected in the region of mouse brainstem to knockout Lis1 in mice. Alternatively,
recombinant adenoassociated viral (rAAV) vectors expressing Cre recombinase
can be microinjected into distinct mouse brain regions to selectively knockout
Lis1(Schierberl and Rajadhyaksha, 2013). However, sterotaxical injection of
tamoxifen in the mouse brain may not activate the same subset of neurons that
are expressing GFP upon IP injection. If loss of Lis1 specifically in brainstem
causes lethality in adult mice, it will suggest that depletion of Lis1 in brainstem
dramatically alters the neuronal function, which may lead to devastating
consequences.
Although we have provided some information on low-dose tamoxifen
induced Lis1 knockout mice, further experiments will be needed to characterize
the phenotype with loss of Lis1. Moreover, adjusting the dosage of tamoxifen
injected in the animal, we can generate different levels of mosaicism which would
result in different phenotypes(Espinosa et al., 2014). By identifying regions that
have undergone the recombination, the role of Lis1 in these regions can be
investigated. Low doses of TM induce recombination in a small set of cells, which
may circumvent the lethality observed in high dose tamoxifen induced Lis1
knockout mice.
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Because its essential roles in brain development, the majority of Lis1
mutant mice generated have been aimed at elucidating the effects of Lis1
depletion during developmental stage. Our inducible Lis1 kn#ckout mouse is one
of the few mouse models that studied the role of Lis1 in mature mammalian
system. The progressive decline and lethal phenotype is unexpected but
interesting. Axonal pathology observed in presumably motor neurons in
brainstem indicated the possible link between neuronal dysfunction and
disruption of Lis1/dynein pathway. Given the fact that Lis1 is a dynein regulator,
mutation in dynein heavy chain result in progressive motor neuron degeneration
in heterozygous animals(Andersen, 2003). Defects in dynein dependent axon
transport have been linked to motor neuron degeneration in mice. Thus, it will be
reasonable to examine how loss of Lis1 alters Lis1 and dynein interactions,
distribution or activity under pathological conditions. Potential changes in
interacting proteins can be monitored by IP-Western with the 74.1 DIC antibody.
We can also determine if dynein is more or less likely to co-pellet with
microbubules from inducible Lis1 knockout brain.
There are several limitations in the current study. First, although Lis1
protein decrease has been demonstrated by western blot in the whole brainstem
of mutant mouse, a more detailed description for the specific cell types affected
by Lis1 knockout in adult mice has not been examined. This should have been
achieved by immunostaining on tissue sections, however, the Lis1 antibody used
in the current study is not suitable for immunostaining on tissue sections.
Therefore, the pattern of Lis1 knockout is demonstrated indirectly by GFP
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expression of R26GT transgene. For future study, we can use a commertially
available Lis1 antibody H300, a rabbit polyclonal IgG to accurately examine Lis1
expression in various tissue. Secondly, the axon transport study was only
performed on cultured sensory neurons which may not provide direct information
on the effect of loss of Lis1 on motor neurons in brainstem. It is difficult to do
transport study on tissues. However, an approach has been established to allow
single cargo analysis in motor axons in situ. By utilizing a Thy1-MitoCFP
transgenic mouse which selectively labels neuronal mitochondria, the flux of
fluorescently labeled mitochondria could be measured in intercostal nerves in
trangularis sterni nerve muscle explants(Bilsland et al., 2010; Marinkovic et al.,
2012). In addition, axonal morphology in brain tissues has not been examined in
this study. In human neurodegenerative disorder dystrophic neurites are filled
with autophagic vacuolar structures that can be visualized by electron
microscopy(Nixon, 2007). Developmental Lis1 heterozygosity resulted in
changes in dendrites in the adult hippocampus, but it was not clear whether this
reflected a developmental defect or a later onset event(Fleck et al., 2000). We
can compare dendritic arbors in inducible Lis1 knockout and control mice using
Golgi Staining. Thirdly, the ultimate death of the inducible Lis1 knockout mouse
prevents further analysis at later stages. Thus, other Cre lines with more specific
expression pattern could be considered in future. For instance, the Camk2aCre/ESR1 strain, available through the European Mouse Mutant Archive, carries
an inducible Cre recombinase under the control of regulatory elements of the
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CAMK2a gene, would permit analysis of neuronal effects in the cortex and
hippocampus.
The current study exploits the technique of tamoxifen inducible knockout to
study the role of Lis1 in adult mammalian system. To our knowledge, this is the
first study that investigates the effects of deletion of double alleles of Lis1 in adult
system using a inducible knockout mouse model. The findings from this study
demonstrate the importance of Lis1 in adult mammals. We provide a novel model
system to explore the function of Lis1 in intact animals and a model for potential
therapeutic intervention to counteract symptoms of lissencephaly that may arise
post-developmentally as a result of transport defects.
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